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ABSTRACT
The Notch signaling pathway is a core component of multicellularity; enabling cells
to directly communicate with both their neighbors and the surrounding microenvironment.
These signals are translated directly through the Notch proteins, where a fragment of Notch
transitions into the nucleus to act as a co-transcription factor, setting into motion a host of
physiological responses. Commonly involved in pathways that define a cell’s identity and
fate decisions, what appears to be a simplistic pathway instead exists in a state of hightunability and strict control. Missteps in this pathway are generally embryonically lethal or
lead to a suite of congenital disorders and cancers. Therefore, it’s pertinent to understand
the mechanisms of Notch that provide its flexibility and pleiotropic outcomes. One such
property is its ability to homodimerize on DNA while within its transcriptional activation
complex, resulting in an enhanced transcriptional signal of a select pool of Notch target
genes. This dissertation reviews the general mechanics behind Notch signaling, discusses
how the field of Notch dimerization came to be and where it stands currently, and finally,
details my contributions to the understanding of this regulatory mechanism. Despite
Notch’s ubiquitous function in metazoan life, there are still many mysteries behind this
signaling pathway. The work detailed here describes my time spent as a basic science
researcher, where my findings contribute a couple of puzzle pieces to the expansive Notch
signaling field.
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CHAPTER ONE: INTRODUCTION
Classical Notch Signaling
The Notch signaling system is a core component of multicellularity; utilized across
the metazoan spectrum with components of the pathway found in even earlier common
ancestors

1–3

. These ubiquitous signaling proteins engage in cell-to-cell contacts and

through this mechanism, control processes such as differentiation, cell identity, and
maintenance of tissue homeostasis. When dysregulated, either through direct Notch
mutations or other indirect mechanisms, it can result in an assortment of genetic disorders
and cancers (thoroughly reviewed by Siebel & Lendahl, (2017) 4). Amusingly, phenotypic
mutations within Notch signaling resulted in its initial identification, where over 100 years
ago landmark studies first described ‘Notches’ in Drosophila melanogaster wings

5,6

(Figure 1.1A). As the field of genetics progressed, a Notch gene from fruit flies was first
cloned, sequenced, and initially characterized in the 80s 7–10. Finally, developments within
the fields of cell and molecular biology have surged research on Notch signaling forward
to where it is today (summarized in Figure 1.1B). This introductory chapter aims to
summarize the field as it currently stands; including both Notch signaling at large and a
specific signaling mechanism, the dimerization of the Notch intracellular domain. The
following chapters within this dissertation detail my contributions to this ever-evolving
field.
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Figure 1.1:

Landmark Studies Concerning Notch’s Function and Dimerization

A) Adapted from his original manuscript, Dexter JS. (1914) The Analysis of a Case of
Continuous Variation in Drosophila by a Study of its Linkage Relations. The American
Naturalist. 48(576): 712-758., Dexter described a Beaded wing, D. melanogaster line,
with “Perfect Notched” wings. This phenotypic observation is the namesake for the
Notch signaling pathway. B) A timeline representing over a hundred years of Notch
signaling research, emphasizing the last forty years of progress. Selected publications
represent landmark studies with key findings of what the Notch protein is, identification
of its structural domains, how it functions, and eventually, how it signals through NICD
dimerization. The following table lists these breakthrough manuscripts and their key
finding(s).

3
Authors (First and Last), Year Published,
Reference Number
Hunt TH (1911) 5
Dexter JS (1914) 6
Kidd S, Young MW, et al. (1983) 8
Artavanis-Tsakonas S, Yedvobnick B, et al. (1983) 10
Wharton KA, Artavanis-Tsakonas S, et al. (1985) 9
Kidd S, Young MW, et al. (1986) 7
Breeden L and Nasmyth K (1987) 11
Lux SE, Bennett V, et al. (1990) 12
Rebay I, Artavanis-Tsakonas S, et al. (1991) 13
Weinmaster G, Lemke G, et al. (1991) 14

Critical Finding, Emphasis on
NICD Dimerization
Notch Fly Phenotype
Notch Fly Phenotype
Notch Gene Identification (Fly)
Notch Gene Identification (Fly)
Sequence, Structure Prediction
Sequence, Structure Prediction
Ankyrin Repeats Identification
Ankyrin Repeats Identification
Receptor/Ligand Activation
Notch Gene Identification
(Mammal, Rat)
15
Rebay I, Artavanis-Tsakonas S, et al. (1993)
Extracellular = Regulatory,
Intracellular = Activity
16
Lieber T, Young MW, et al. (1993)
Ankyrin domain is necessary,
NICD found in the nucleus
17
Tun T, Kawaichi M, et al. (1994)
RBPJ DNA binding sequence
Jarriault S, Israel A, et al. (1995) 18
Notch interacts with RBPJ,
Interaction induces gene
transcription
Bailey AM and Posakony JW (1995) 19
Sequence-paired site Identification
20
Tamura K, Honjo T, et al. (1995)
RBPJ and NICD’s RAM
interaction
21
Kato H, Honjo T, et al. (1996)
Comparison of the Notch1-4 family
members
22
Kopan R, Nye JC, et al. (1996)
Canonical Activation
Schroeter EH, Kopan R, et al. (1998) 23
Canonical Activation
Nellesen DT, Posakony JW, et al. (1999) 24
Sequence-paired site Identification
25
Wu L, Griffin JD, et al. (2000)
MAML1 interacts with NICD
Kitagawa M, Harigaya K, et al. (2001) 26
MAML1 interacts with NICD
27
Cave JW, Caudy MA, et al. (2005)
Sequence-paired site Identification
Ong C, Kopan R, et al. (2006) 28
Sequence-paired site Identification,
Thorough Promoter Analysis
Nam Y, Blacklow SC, et al. (2007) 29
Ankyrin-mediated Dimerization
Model
Arnett KL, Blacklow SC, et al. (2010) 30
Ankyrin-mediated Dimerization
Crystal
Liu H, Pear WS, et al. (2010) 31
Dimerization’s Physiological
Relevance
32
Vasquez-Del Carpio R, Capobianco AJ, et al. (2011) Anti-parallel Dimerization Model
Castel D, Stunnenberg HG, et al. (2013) 33
Sequence-paired site Identification
34
Hass MR, Kopan R, et al. (2015)
Sequence-paired site Identification
Severson E, Aster JC, et al. (2017) 35
Analysis of Cryptic SPSs,
Sequence-paired site Identification
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Protein Structure and Processing
As a transmembrane signaling protein, Notch can be readily split into two
functional halves. The extracellular region interacts with neighboring cells to receive
signals from their displayed ligands, while the intracellular region translates this signal into
transcriptional responses. For a structural summary of the Notch1 receptor, refer to Figure
1.2, where each indicated subdomain will be discussed in the following sections.
The Extracellular Domain
Throughout its lifetime the Notch protein is continuously processed and cleaved to
elicit or inhibit its transcriptional capabilities. The first cleavage event occurs during its
initial maturation before it traffics to the plasma membrane, where within the trans-Golgi
network it is cleaved by the convertase Furin (or Furin-like proteases) at the S1 cleavage
site

36,37

. Interestingly, cleavage at this location is not necessary for normal Notch

extracellular domain folding or further proteolysis, but instead is required for standard
trafficking to the cell surface

38,39

, though this mechanism is not well understood. As a

mature protein, the extracellular and intracellular halves of Notch are held together by
several interdomain non-covalent interactions. The first is through a region termed the
heterodimerization domain (HD) which consists of hydrophobic and electrostatic
interactions, rejoining the two Notch parts separated by S1 cleavage. Importantly, the HD
contains an internal S2 cleavage site which is covered and protected by the other set of
interdomain contacts, the three Lin12/Notch repeats (LNR)

40,41

. Altogether, these

components and contacts form the negative regulatory region (NRR) and its activation will
be further explored in the ‘Signaling Mechanism’ section.

5
Beyond this crucial regulatory region lies the Epidermal Growth Factor (EGF)-like
repeats which make up the bulk of the extracellular domain. These repeats are heavily posttranslationally modified by several forms of O-linked glycosylation and act to regulate
Notch signaling through its interactions with partner ligands. This regulation is variable
based on the EGF-like repeat composition of the different Notch receptors, what ligands
are available to interact with, and even depends on cell-specific contexts which dictate how
the EGFs are first modified (thoroughly reviewed by Harvey & Haltiwanger, (2018);
Gordon et al., (2008) 42,43).
The Intracellular Domain
Soon after the S2 site within the HD is a transmembrane-spanning domain,
followed by the remainder of the Notch protein; the Notch Intracellular Domain (NICD).
Located within the transmembrane-spanning region are the S3 and S4 cleavage sites, both
cleaved by the presenilin/γ-secretase complex. The S3 cleavage site is near the cytosolic
side of the plasma membrane 23, though the exact cleavage location and the resulting start
of the N-terminus of the NICD are variable based on if the Notch protein goes through
traditional ligand-induced activation or endosomal-mediated signaling

44,45

. The S4

cleavage site is found near the middle of the transmembrane spanning region and, when
cleaved, results in the secretion of a small extracellular/intramembrane fragment 46,47.
Starting immediately after the S3 cleavage sites is the NICD, the transcriptionally
active, “dissertation-relevant” portion of the Notch protein. It consists of three large
domains with a plethora of other regulatory elements within. To be discussed in length in
the upcoming ‘Transcriptional Activation Complex’ and ‘Notch Intracellular Domain
Dimerization’ sections, Notch is a co-transcription factor which interacts with the DNA-

6
binding protein Recombination signal Binding Protein for immunoglobulin kappa J region
(RBPJ), also commonly called CSL, for CBF-1/Suppressor of Hairless/Lag-1. This
interaction with RBPJ is initiated through the first of NICD’s large domains, the RBPJ
associated module (RAM) domain 20,48.
The second large domain is composed of ankyrin repeat (ANK) motifs, which are
individually made up of two antiparallel α-helices connected by a short loop, with tandem
ankyrin repeats linked together by longer loops 49. Notch contains seven of these ankyrin
repeats, and this domain is essential for transcriptional activation of target genes by
mediating protein-protein interactions

18,50

. Critically, when an active NICD molecule

binds to a DNA-bound RBPJ protein, this complex further recruits a Mastermind-like
(MAML) family member through interactions with both RBPJ and NICD’s ankyrin
domain 51.
The third large domain is the transactivation domain (TAD), which is the least
characterized region within the Notch proteins. Its presence in Notch1 is a requirement for
successful activation of target genes 52,53, yet its structural characteristics and interactions
aren’t well defined. Overall, it’s thought to augment Notch1-induced transcription by
playing roles in the assembly of the Notch1/RBPJ/MAML ternary transcription complex
54

, and may also be involved in the recruitment of other transcriptional machinery, like

histone acetyltransferases 55,56.
Beyond these large domains are several smaller structural features and a wide array
of post-translational modifications. These modifications range from the assortment of
glycosylations

on

the

EGF-like

repeats,

to

protein

attachments

(ubiquitination/sumoylation), and a plethora of other transient, amino-acid level

7
modifications

(phosphorylations/acetylations/methylations/hydroxylations),

thoroughly reviewed in Antfolk et al., (2019)

57

all

. Other minor, yet critical, structural

features include two nuclear localization signals (NLS)

50,58

and a Proline/Glutamic

acid/Serine/Threonine (PEST) domain, which is involved in the Notch protein’s rapid
degradation

59,60

. An EP domain has also been described within the C-terminus of the

ankyrin domain which recruits the histone acetyltransferase p300 61,62. However, whether
it holds this specific function or if it just aids in the stability of the ankyrin domain, which
itself has larger implications, is up for debate 63,64.

Figure 1.2:

Structural Domains of Notch1

The functional domains of the mouse Notch1 protein. As a transmembrane (TM) receptor,
Notch can be readily split into two functional regions: the extracellular region which
receives signals from neighboring cells and the intracellular region, which translates these
signals into transcriptional outputs. This diagram represents a Notch protein that has
already been cleaved with Furin at the S1 site, reassembled through the heterodimerization
domain, and is primed for activation. EGF-like repeats 8-13 have been identified through
color shading, arrows indicate the minimal EGF-like repeats required for Notch activation;
repeats 11 and 12 (further discussed in the ‘Signaling Mechanism’ section). In this figure,
the Notch protein and its domains have been scaled accordingly for relative size.
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Differences Between the Notch Receptors
Historically, the majority of original structural work was through research on the
D. melanogaster and C. elegans Notch receptor, and fortunately, due to the high
conservation of this pathway, most of the identified domains are equivalently found in the
vertebrate Notch receptors. Within the vertebrate Notch family, however, there are some
noteworthy differences. There are four members of the mammalian Notch family, aptly
named Notch1 through 4, which all play roles in development though with varying degrees
of importance and overlapping functions. For example, Notch1 and Notch2 knockout mice
are embryonically lethal, whereas mice without Notch3 and Notch4 were viable and fertile
(whole-animal and tissue-level, conditional Notch knockouts are reviewed in Hozumi,
(2020) 65).
At a structural level, the four Notch proteins are mostly homologous, though with
several distinct differences. First, the EGF-like repeats are variable among the Notch
proteins: there are 36 repeats in Notch1/2, 34 in Notch3, and 29 in Notch4

66,67

, though

they all still contain EGF11 and 12 which are crucial for receptor-ligand interaction
(discussed in the ‘Signaling Mechanism’ section, also in Fleming, (1998)

68

). This

variability in the number of repeats, combined with the substantial amino acid differences
between their respective EGF-like repeats

69

, may allow the Notch receptors to have

preferential ligands and other extracellular interactions.
Second, the presence and functionality of the TAD domain is disputed for the Notch
receptors. As for the presence of the TAD domain, none of the other Notch proteins have
a C-terminus that strictly resembles the TAD found in Notch1, though the equivalent region
in Notch2 does behave somewhat similarly

52

. In contrast, a Notch1-esque TAD is

9
nonexistent in Notch3 and 4, though the C-terminal region past the ankyrin domain in
Notch3 does interact with some zinc finger-mediated transcription factors, resulting in its
trans-activation 28.
Finally, there are mixed reports about if the Notch4 protein is even capable of
canonical Notch signaling, despite having all the necessary domains for minimal activity.
In all cases, a constitutively active Notch4 intracellular domain could induce transcriptional
signal, so the question lies in if the extracellular domain can bind to a ligand and induce
the cascade of cleavages to release the N4ICD. This question is commonly addressed
through co-culture experiments, where one cell type has the Notch4 receptor and is grown
alongside another cell type presenting a Notch ligand. Paradoxically, some co-cultures with
cells presenting the Notch ligands Delta-like 4 or Jagged1 weren’t capable of activating
Notch4

70,71

, whereas other co-cultures, using the same ligands, did observe Notch4

activation 72,73. Therefore, despite having the same proteins present, the collective results
here are conflicting. This can likely be contributed to the usage of different cell lines or
different overall methodologies, but all told, it’s still unknown if or under what contexts,
Notch4 if capable of canonical Notch signaling.
Signaling Mechanism
All Notch proteins signal through the same activation format. As summarized in
Figure 1.3, Notch proteins are found on the cell surface, primed for activation, awaiting
interactions with a ligand displayed by a physically interacting, neighbor cell. These
interactions induce a cascade of proteolytic cleavages within the Notch protein that results
in the release of the intracellular domain. As a co-transcription factor, the NICD

10
translocates to the nucleus to induce transcription of target genes. The following section
will further explore each step of this signaling mechanism.
After the initial protein cleavage event by Furin, the heterodimerized Notch protein
awaits at the cell membrane in an autoinhibited state. In this state, the S2 cleavage site is
physically protected by the NRR, where if absent or non-functional, the S2 site is readily
available for cleavage and results in a constitutively active Notch receptor

16,40,41,74,75

.

Instead, typical Notch activation is through EGF-mediated interactions with the DSL
(Delta, Serrate, LAG-2) family of ligands (Delta-like 1, 3, 4 (DLL1,3,4), and Jagged1, 2
(JAG1,2) in humans). These ligands (excluding DLL3, see Chapman et al., (2011); Ladi et
al., (2005) 76,77) are present on neighboring cells’ surfaces and interact with the EGF-like
repeats within the Notch extracellular domain. These interactions are mediated through two
ubiquitous domains found within the DSL ligands: an N-terminal C2 phospholipid
recognition domain (also called an MNNL domain)

78,79

, followed by a DSL domain

80

.

These structural components and interactions are thoroughly reviewed in Handford et al.,
(2018) 81.
Among the many EGF-like repeats within Notch, substantial mutational analysis
initially uncovered that the repeats 11 and 12 were critical for signaling

13

repeats alone were not enough for complete ligand-mediated activation

15

, though these

. The scope of

necessary EGF repeats has expanded since then, where an assortment of other studies
implicate repeats 8-13 and beyond to mediate ligand-receptor affinity and preferences 82–
88

. Nevertheless, in an antiparallel fashion, the glycosylated Notch EGF repeats 11 and 12

are the minimum required for ligand-receptor interactions. In Figure 1.2 and 1.3, these
repeats have been differentially shaded (8-13) and further identified through arrows (11-

11
12). The engagement between the Notch receptor’s repeats 11 and 12 and a potential ligand
is through the C2 and DSL domains of a partnered DSL ligand 89 and is sufficient to induce
the next step in the activation pathway: ligand-induced proteolysis.
Upon Notch-ligand engagement, the signal sending cell endocytoses the DSL
ligand through Clathrin-mediated processes 90,91. The mechanism or triggering behind this
event is not well understood, though evidence suggests that ligand endocytosis is not
random or consistently occurring, but instead depends on a Notch extracellular domain
interaction

92

. Regardless, this endocytosis transfers a mechanical force through the

heterodimerized Notch receptor, inducing an unfolding event within the NRR

91–95

.

Previously compared to a mushroom cap protecting its stem, the LNR domains cover and
protect the S2 cleavage site found within the HD domain 43. Through the endocytotic force,
the LNR domains unfold and open the S2 site for cleavage by members of the ADAM (a
disintegrin and metalloprotease) protease family 96–98.
The primary ADAM member utilized for ligand-induced proteolysis is ADAM10,
though some evidence suggests that ADAM17 is also capable of ligand-independent
cleavage of Notch

99–103

. As membrane-bound proteases, they can be classified as

sheddases where, as in the case of Notch, they cleave the extracellular portion of proteins
from the cell surface. The extracellular Notch fragment, still bound to the DSL ligand, is
then completely endocytosed into the signal sending cell and targeted for degradation

92

.

The other portion, the membrane-spanning and intracellular domain, is further cleaved at
the S3 and S4 sites.
These sites are found within the transmembrane spanning region and are cleaved
by the γ-secretase complex, also an integral membrane protein (reviewed in Jorissen & De
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Strooper, (2010)

104

). Among other structural components, its catalytic subunits are

Presenilin 1 or 2, and these are necessary for the complex to cut Notch and cause the release
of the intracellular domain 105,106. Protein cleavage through γ-secretase is prevented in the
presence of a large extracellular domain

107

, and therefore, this final cleavage step is

regulated by the action of the ADAM proteases. The two cleavage sites are cut sequentially
(S3 then S4), and the S3 site ends up dictating the new N-terminus of the NICD

44,46,108

.

Canonically, the new N-terminus amino acid is Valine 1744 (for mouse N1ICD, human
N1ICD is V1754) but the exact cleavage site can be variable. An alternative, though
uncommon, cascade of NICD processing and signaling involves an endocytosis-mediated
mechanism, and this subfield is still in development

44,109–112

. Post cleavage, the Notch

intracellular domain, through its internal nuclear localization signals, is then translocated
and imported into the nucleus through the canonical importin-α/β1 transport pathway
113,114

. Here, the functional roles of the Notch signaling pathway take place.

Transcriptional Activation Complex
Within the nucleus is the transcription factor RBPJ, where it interacts with its
cognate DNA binding sites within gene enhancers and promoters. This protein has three
functional domains: an N-terminal and C-terminal Rel-homology region (RHR-N or -C),
and a beta-trefoil domain (BTD) between them 51,115. The RHR-N and BTD interact with
the DNA’s major and minor groove, respectively, resulting in its transcription factor nature
51,115,116

. Importantly, the BTD and RHR-C include the sites for protein-protein

interactions, including the interaction with the RAM domain of the NICD, along with a
suite of interactions with corepressors

115,117,118

. Notably, RBPJ’s default state is one of

repression, where the interacting co-repressors differ based on specific cell types or tissues
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and the state of development of those cells (thoroughly reviewed in Oswald & Kovall,
(2018); Contreras-Cornejo et al., (2016); Borggrefe & Oswald, (2009); 119–121).
An active Notch signaling pathway works to displace the co-repressors bound to
RBPJ and instead recruit its own co-activators to drive transcription of target genes. For a
bit of history, the first observations of an RBPJ-Notch interaction was well over twenty
years ago
18,20,123,124

122

, and was quickly verified in both vertebrate and invertebrate systems

. This signaling system has distinct biological functions, dependent on

interactions between RBPJ and Notch, and was observed to occur between each of the four
mammalian Notch proteins 21,48.
The transition from corepression to coactivation starts with binding of the NICD
RAM domain to RBPJ, which displaces any interacting co-repressors

125

. This protein-

protein interaction results in a new binding interface created between RBPJ and the ankyrin
domain of Notch, where a member of the MAML family is recruited and binds, creating a
ternary complex (RBPJ/NICD/MAML, annotated in Figures 1.3 and 1.4) 25,26,51,117,126–129.
The MAML protein can be considered the catalyst for Notch-regulated transcription, as it
recruits an assortment of transcriptional machinery (reviewed in Kitagawa, (2015)

130

).

First, MAML1 has been shown to recruit p300/CBP, PCAF, and GCN5 which are all
histone acetyltransferases and promote nucleosome acetylation

55,56,61,121,131,132

. Second,

MAML1 induces the recruitment of RNA polymerase II for gene transcription. Beyond
acetylating DNA, p300/CBP also acetylates MAML1 which creates docking sites for the
protein PEAK1 related, kinase-activating pseudokinase 1 (also commonly called NACK
and Pragmin). Through currently unknown mechanisms, NACK recruits RNA polymerase
II, leading to transcription initiation 133,134.
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Figure 1.3:

Activation of the Notch Signaling Pathway

The activation of the Notch signaling pathway can be summarized into four essential steps,
detailed in the above sections. 1) A signal sending cell presents a ligand from the DSL
family which interacts with a Notch receptor on the signal-receiving cell’s surface. Ligandreceptor recognition, mediated primarily through the ligand’s DSL and C2 domains
interacting with the receptor’s EGF-like repeats 11 and 12, induces endocytosis of the DSL
ligand. This places a mechanical pulling force on the attached Notch receptor, inducing an
unfolding event of the NRR. 2) This unfolding event allows a series of proteolytic cleavage
events; first at the S2 site by an ADAM metalloprotease and then at the S3 site by the γsecretase complex. 3) These two cleavage events release the transcriptionally active
intracellular domain which is free to translocate to the nucleus through the utilization of its
nuclear localization signals. 4) Within the nucleus, NICD assembles into a ternary complex
with RBPJ and a member of the MAML family. This complex recruits further
transcriptional machinery, primarily through interactions with MAML, and eventually
drives transcription of Notch target genes.
Signal Inhibition and Protein Degradation
The canonical route for Notch degradation is through the utilization of the Notch
PEST domain, though cells utilize several other signaling pathways to turnover and
finetune the amount of Notch signal (thoroughly reviewed in Francesca A. Carrieri & Dale,

15
(2017)

135

). As for PEST-mediated degradation, this route begins immediately after the

initiation of gene transcription through the ternary Notch complex. To start, members of
the MAML family, all while within the ternary complex, recruit an assortment of kinases
that phosphorylate the NICD

131

. This includes the Cyclin C/Cyclin-dependent kinase

complex (CycC:CDK1, 2, or 8) which bind directly to MAML and phosphorylate serines
and threonines within the NICD TAD and PEST domains

136,137

. The serine/threonine

kinases Glycogen synthase kinase-3α/β (GSK-3α or β) are similarly involved
phosphorylating amino acids within the PEST domain, but their method of recruitment and
regulation is less understood 138–140. These modified amino acids within the PEST domain
form a phosphodegron motif which acts as a specific substrate binding region for the Fbox/WD repeat-containing protein 7 (FBXW7), a member of the Skp, Cullin, F-box
containing complex (SCF complex), and together act as an E3 ubiquitin ligase 59,60,141–147.
After ubiquitination, the transcriptional signal is halted, the transcription factor complex
falls apart, and the NICD is recycled in the proteasome through canonical mechanisms.
While the final proteasome degradation is the same, the route there can change
based on alternative mechanisms of Notch signaling or slight protein modifications based
on cellular contexts. For some mechanistic examples, there are phosphodegrons found
within the RAM and ankyrin domains, regulated through a yet to be identified E3 ligase
148

and through the E3 ligase Itch (also named AIP4) 149,150. In both of these cases, Notch

is signaled for degradation while still in a non-activated state, either before interactions
with RBPJ

148

or even at the cell membrane before ligand activation

151–153

. As far as

regulation based on cellular context goes, some examples include integrin-linked kinase or
the Src family kinases which phosphorylate select serine/threonines or tyrosines,
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respectively, found within the Notch ankyrin domain. Their amino acid targets indirectly
affect Notch stability through the inactivation or recruitment of other kinases or complex
proteins 154–157. Altogether, these degradation mechanisms allow for the rapid and precise
responses to changes in Notch signaling to meet the needs of the cell.
Notch Intracellular Domain Dimerization
Promoter Structure
Canonical Notch target genes, such as those within the hairy and enhancer of split
family (Hes1-7) and the Hairy/enhancer-of-split related with YRPW motif protein family
(Hey1, 2, L), transition the Notch signal and act as transcriptional repressors (reviewed in
Davis & Turner, (2001); Fischer & Gessler, (2007)

158,159

). Among a variety of other

promoter elements that all regulate gene transcription, these Notch-target genes generally
contain multiple RBPJ recognition sequences. This sequence motif, 5’-CGTGGGAA-3’,
has not dramatically changed since it was first identified 17, though we now understand that
not every base has equivalent nucleotide-RBPJ interactions

35,160,161

. The core RBPJ

recognition sequence is 5’-YGTGRGAA-3’, where ‘Y’ is a pyrimidine base (C or T) and
‘R’ is a purine base (A or G). 4
Screening for this consensus motif within the Hes family-equivalent Drosophila
promoters (Enhancer of split complex genes, such as E(spl)m4, 8, γ) identified two
important trends. First, these promoters are controlled by multiple RBPJ binding sites
(Su(H) protein in Drosophila) spread throughout, both in the proximal promoter and distal
enhancers. Second, and significantly relevant to this dissertation, a select number of these
sites were in a ‘paired’ arrangement, abbreviated as an SPS (Su(H) paired site) 19. An SPS
was originally characterized as two RBPJ binding sites in the forward (sense) and reverse
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(antisense) orientation, separated by a defined number of nucleotides (16 bp) that was
conserved between the Drosophila E(spl)m4, m8, mγ and mouse Hes1 genes (this
separating space has been termed as ‘spacer’ or ‘gap’ distances). Herein, it was first
hypothesized that the SPS permits synergistic interactions between two Notch ternary
complexes 19. This SPS motif was later identified in more members of the E(spl) complex
genes and its necessity for gene transcription was further explored. Interestingly, its
presence was required for some Drosophila developmental aspects but not in others 24.
Cave et al. (2005) 27 further defined the SPS architecture to only include the forward
and reverse site orientations. Manipulation of these sites into other arrangements, such as
forward-forward or into a single RBPJ binding site, severely ablated any transcriptional
activation from the promoter element

27

. Using a Drosophila cell culture model, Cave et

al. also observed further synergism with another promoter element, a so-called ‘A site,’
where proneural basic Helix-Loop-Helix (bHLH) activator proteins bind. Only when in
combination with the bHLH activator proteins Achaete and Daughterless was the
Drosophila NICD able to robustly activate the E(spl)m8 promoter, which contains both an
SPS and A site motif. On a synthetic promoter within mammalian cells, this combination
(SPS + A) resulted in substantial promoter activation only when transfected with both
NICD and the proneural bHLH activator protein MASH1, and displayed poor activation
when only one of these transcription factors was present 27. However, this specific promoter
arrangement has not been further identified or explored in any native mammalian Notch
target genes, suggesting that the SPS + A code may be a Drosophila-specific mechanism.
The first comprehensive mammalian promoter analysis was by Ong et al. (2006) 28,
where the authors explored the promoter activation potential of each Notch family member
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(Notch1-4) on a suite of native, mutated, and synthetic promoters in a variety of
mammalian cell lines 28. As hinted at in a previous study 162, they found that the four NICDs
have substantially different activation strengths, even on the same promoter. In general,
Notch1 is the strongest activator, and Notch3 and Notch4 compete for the ‘weakest NICD’
title. Their relative activities, therefore, likely depend both on their amino acid
compositions and various regulatory interactions dependent on cellular contexts. Since the
four mammalian Notches equivalently interact with the same RBPJ protein

161,162

, their

variable activation strengths may be attributed to either structural differences within their
ankyrin or C-terminal domains, or within cis-regulatory elements found within different
promoters and cell types.
To address these two possibilities, Ong et al. performed substantial promoter
mutagenesis on Notch-target genes to find the minimum promoter elements required for
Notch-induced transcription. Strikingly, they found that the SPS within Hes1 (with an
additional TATA box) is the minimal promoter element necessary for robust Notchinduced activation. Further, this minimal SPS-induced promoter had variable activation by
the different Notch proteins (N1 > N2/4 > N3), all while within the same cell type. This
indicates that the different strengths seen in full-length promoters can be primarily
attributed to the amino acid composition of the individual Notch proteins, not cisinteracting promoter elements 28.
The latter half of their manuscript sought to determine the minimum requirements
and signaling potential of sequence-paired sites. In summary, their work confirmed the
characteristics identified by the original landmark studies 19,24, where SPSs are composed
of two RBPJ binding sites oriented head-to-head, with precisely 16-nucleotides between
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them 28. Further, they demonstrated that they can artificially create a canonical SPS from a
monomeric RBPJ-site within Hes5, which dramatically increased its transcriptional
potential, and any non-canonical formats performed poorly. This agrees with results from
Cave et al., who also found the orientation and spacing between these two RBPJ-sites was
crucial for activation; any deviation from the canonical motif nulls the transcriptional
response. While the promoter mutagenesis performed by Ong et al. indicates the inflexible
nature and importance of an intact SPS motif, the mechanistic details behind its NICDinduced activation were again left unanswered.
Notch Dimerization: The First Observations
Just a year after the Ong et al. (2006) paper was published, the question regarding
the mechanism behind Su(H) paired sites was addressed. The Blacklow laboratory utilized
a Notch ternary complex crystal structure (PDB ID: 2F8X) they had previously solved to
model two Notch transcriptional activation complexes (NTC) on DNA 29,126. This original
crystal structure includes partial proteins of RBPJ, MAML1, and N1ICD, as well a segment
of the Hes1 promoter including a single, canonical, RBPJ binding site. When observing
their ternary complex crystal, as well as a crystal structure of the Notch1 ankyrin domain
solved by another independent group 163, they noticed points of contact between the convex
surfaces of adjacent NICD ankyrin domains. These contact points led to two important
observations: 1) interacting complexes orient in a head-to-head conformation (two NICDs
facing each other, as they would be oriented on an SPS) and 2) when connected through
the ankyrin domains, the resulting distance between the two NTCs is roughly equivalent to
the distance between the two RBPJ binding sites of an SPS. Further, the amino acids
implicated in dimerization are conserved both across Notch homologs and within a range
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of species

29

. These few observations led the Blacklow laboratory to hypothesize the

possibility of NICD dimerization, explore any transcriptional implications of this process,
and practically started the field of Notch intracellular domain dimerization. Culminating
their work, Figure 1.4 represents the structure, orientation, and interacting amino acids used
for NICD dimerization.

Figure 1.4:

Crystal Structure of a Dimerized Notch Ternary Complex

A dimerized NICD ternary complex assembles on the head-to-head RBPJ binding sites
within a sequence-paired site. This structure is assembled on the human Hes1 SPS, and is
composed of human RBPJ, a fragment of MAML1, and the ankyrin domain of Notch1.
The ternary complex proteins are labeled respective to their colors within the figure. The
inset box indicates the conserved dimerization interface and the panel to the right is an
expanded view of this region. Interacting amino acids are identified (green) and their
corresponding amino acids in the reciprocal protein can be found in orange. This crystal
structure was solved by Arnett et al., (2010) 30, submitted to the RCSB Protein Data Bank
(ID: 3NBN), and further visualized in the EzMol software wizard developed by Reynolds
et al., (2018) 164.
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Dimerization as a Transcriptional Activator
By modeling two NTC cores on an SPS (hereafter an abbreviation for ‘sequencepaired site,’ as it changed with the literature), Nam et al. (2007)

29

observed three

electrostatic points of contact between the two dimerizing ankyrin domains. The first
includes hydrogen bonds between the guanidino group of R1984 (amino acids and
positions represent those found within human Notch1) and three backbone carbonyl
oxygen atoms within the partner ankyrin domain. The second interaction includes salt
bridges between E1949 and K1945 of the two ankyrin domains, and the third includes
hydrogen bonds between R1982, S1951, and a backbone carbonyl oxygen atom 29.
While these contacts were sufficient for ankyrin-dependent dimerization, Nam et
al. were curious if dimerization was necessary for transcriptional activation through a
gene’s SPS. This was tested through mutational analysis of the dimerizing amino acids and
they found that, upon null-mutations (primarily of R1984, R→A), transcriptional
activation of a Hes1 luciferase reporter was abrogated 29. Similarly, through the utilization
of electrophoretic mobility shift assays (EMSA) on the Hes1 SPS, wild-type proteins were
capable of cooperatively loading onto the promoter segment, whereas dimerizing-mutants
abrogated any complex assembly. To further characterize SPS limitations through EMSA
analysis, Nam et al. both expanded and shortened the gap distance between the two RBPJ
binding sites. They observed that cooperative loading is slightly flexible, allowing for 1519 bp gap distances (a wild-type gap is 16 nucleotides). To push complex assembly to its
limits, additional mutations of the SPS, such as through site inversions or large nucleotide
insertions between the sites, also disrupted any cooperative complex loading, as seen in
similar previous studies

27,28

. Altogether, this landmark study discovered Notch
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intracellular domain dimerization, associated it with the known mechanisms of sequencepaired sites, and characterized some of its limitations 29. Further, Nam et al. found that this
is a physiologically relevant subset of Notch signaling, where dimerization almost
completely controls transcriptional activation of the SPS-inclusive gene, Hes1.
In a follow-up study 30, the Blacklow laboratory sought to address a problem with
their previous dimerization model: when two NTCs were modeled on an SPS with an ideal
B-form DNA conformation, the dimerization interface was almost 50 Å apart. They preface
that for native dimerization to occur, then the two NTCs, the gap distance DNA, or both
would have to go through substantial conformational change. To address this issue, Arnett
et al. (2010)

30

solved the crystal structure of the entire dimeric complex, using partial

proteins of RBPJ, Notch1, and MAML1, and a 37-bp DNA segment containing the Hes1
SPS (PDB ID: 3NBN), visualized in Figure 1.4. As indicated in their original models, the
crystal structure resolved with the same contacts between the two NTC’s ankyrin domains
and had little overall conformational change of the individual NTCs. Instead, the DNA
went through substantial bending and untwisting to accommodate the dimerized
complexes. Importantly, this suggests that, while the ideal gap distance between two NTCs
is 16 nucleotides 29, alternatively spaced gap distances may accommodate dimeric complex
assembly as well. This was previously explored by Nam et al., but was through mutational
analysis of the Hes1 SPS, not natural gene targets.
In this follow-up study, Arnett et al. identified alternative sequence-paired sites in
genes with a 16-nucleotide (Hes4, FJX1), a 15-nucleotide (SYT14), and a 17-nucleotide
gap distance (CUL1), all of which demonstrated NTC dimerization through EMSA
analysis. Further, to examine the effects of dimerization on canonical Notch-target genes
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without standard sequence-paired sites, they used luciferase reporter assays driven by
promoter sections of HeyL, Hey2, and Hes5. As anticipated, HeyL and Hey2 activated
equivalently with wild-type or dimerization deficient NICDs, but surprisingly, activation
of the Hes5 promoter required dimer formation.
These observations split Notch-responsive promoters into two categories; those
without dimerization dependence (HeyL, Hey2) and those that depended on dimerization
for robust activation (Hes1, Hes5). However, while Hes1 contains a canonical SPS, Hes5
contains several RBPJ binding sites but none in the canonical SPS conformation. To
explore this conundrum, Arnett et al. performed mutation analysis of RBPJ sites within the
promoter to find the cause of dimer dependence. Through further EMSAs, luciferase
assays, and various mutant promoters, they identified a ‘cryptic’ partner site, 16 nucleotides
away from one of the canonical RBPJ binding sites within Hes5 30. This observation adds
a critical aspect to the scope of Notch dimerization: sequence-paired sites may contain
subpar/cryptic secondary RBPJ binding motifs that alone would not normally bind RBPJ.
The presence and activation of a cryptic sequence-paired site results in an important point
of concern that will be a theme throughout the rest of this dissertation: screening and
identifying genes activated through non-standard sequence-paired sites will prove
exceedingly difficult. Altogether, Nam et al. (2007) 29 and Arnett et al. (2010) 30 identified
Notch dimerization as a novel method of transcriptional activation and resulted in the
categorization of Notch target genes based on their utilization of Notch dimerization.
However, these two studies only observed the activation of two dimerization-dependent
genes (Hes1 and Hes5), and all work performed was in vitro, so the field was wide-open
to find further physiological relevance.
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Physiological Relevance of Notch Dimerization
A classical model to study Notch activity is through the normal specification and
maturation of T cells, as well as in the disease state; T-cell acute lymphoblastic leukemia
(T-ALL). For a brief and simplified overview, the differentiation of T cells starts with
hematopoietic stem cells found within the bone marrow. Upon cell division, they create
multipotent progenitor cells which, through extensive cell signaling, are directed down one
of two paths: to become myeloid or lymphoid progenitor cells. Myeloid progenitor cells
are eventually specified to become erythrocytes, megakaryocytes, mast cells, and
myeloblasts, where the myeloblasts are unipotent stem cells and further differentiate into
the granulocyte series. The lymphoid progenitor cells can differentiate into natural killer
cells or a precursor cell which further differentiate into T or B lymphocytes. Most of the
differentiation steps during hematopoiesis occur in the bone marrow and some in the blood
stream, but of note, T cell maturation is unique in that it occurs in the thymus.
Among the large array of cytokines, surface proteins, transcription factors, and
other signaling molecules involved in hematopoiesis, among them, the Notch signaling
pathway is best known for its role in T cell development. Simply summarized, active Notch
signaling transitions the lymphocyte precursor into T cells and is further involved in their
maturation in the thymus, whereas inhibited or inactive Notch signaling in the bone marrow
results in a B cell lineage. These lineage decisions are normally regulated due to the
presence or absence of Notch ligands on bone marrow stromal cells and thymic epithelial
cells. However, when Notch-activating mutations occur within the lymphoid progenitor
cell line, this commonly results in T cell leukemia. T-ALL is a result from constitutively
activating mutations within Notch, commonly within the HD or PEST domains. Mutations
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within the heterodimerization domain result in ligand-independent Notch signaling,
whereas PEST mutations stabilize the activated Notch intracellular domain. Lesseractivating mutations within Notch are unable to induce T-ALL by themselves, though in
combination with other oncogenic hits, can result in an accelerated development of
leukemia. While the above summary should provide sufficient basal-level information
about hematopoiesis and the normal and abnormal development of T cells for the rest of
this dissertation, please refer to the following reviews for more in-depth material: Koch &
Radtke, (2011); Radtke et al., (2010); McCarter et al., (2018) 165–167.
The first source of physiological relevance for Notch dimerization was through the
Pear laboratory a few years after the first report of NICD dimerization. Using a mix of in
vivo and in vitro techniques, Liu et al. (2010)

31

discovered that not all Notch-dependent

processes in T cell development require Notch dimerization. This indicates that Notch
dimerization is not some all-encompassing mechanism, but instead regulates the
transcription of specific genes and processes. For example, both wild-type and dimerizing
mutants (Notch1, R1984A) were equally potent in inducing T-cell development from a
multipotent lymphoid progenitor. In contrast, the induction and development of T-ALL in
mice through the expression of a constitutively active NICD in hematopoietic stem cells
only occurred with wild-type NICDs; R1984A mutants remained leukemia-free. This
effect was similarly observed in vitro in two T-ALL cell lines, where wild-type NICD
induced cell growth and R1984A mutants did not 31.
Liu et al. hypothesized that this is due to the NICD R1984A mutant’s failure to
induce the expression of critical target genes essential for leukemogenesis. This question
led to the identification of the other dimer-dependent genes beyond the original Hes1 and
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Hes5. While the NICD induction of Hey1 and CD25 was equivalent between wild-type and
mutant proteins (dimer-independent genes), the dimer mutant failed to activate Hes1 (as
seen previously, 29), c-Myc (a proto-oncogene encoding a transcription factor), and pTα (a
gene encoding a transmembrane protein which is involved in early T-cell development),
classifying them all as dimer-dependent genes. These genes were explored further
throughout the manuscript, utilizing various reporter and cellular assays, combined with
the mutagenesis of proteins and promoters. Together, these experiments indicated that
these were novel, dimer-dependent genes and that NICD dimerization was necessary for T
cell maturation and leukemic cell growth 31.
The conclusion that pTα is a dimer-dependent gene led them to an unexpected
observation: just like Hes5 30, the promoter of pTα did not have a canonical SPS. While the
previously identified RBPJ binding site within the pTα promoter has a near-optimal
consensus sequence

35,168

, there was no standard consensus site found in the antisense

strand, 15-17 bases away, as in a canonical SPS. To explore the possibility and mechanism
of dimerization on the pTα promoter, Liu et al. performed EMSA analysis with the RBPJcontaining fragment, including the area around it. As its dimerization-dependence
suggested, they identified a cryptic RBPJ binding site 16 nucleotides away from the highaffinity site. Interestingly, this secondary site only demonstrated the assembly of an NTC
if the high-affinity site was intact; it alone would not load an NTC. Further, while Liu et
al. did not initially identify the SPS regulating c-Myc, in a follow-up study the Pear
laboratory identified a cryptic SPS, with a 15-nucleotide gap, within c-Myc’s distal
enhancer 169. These cryptic sequence-paired sites will be further explored in the upcoming
manuscripts and in the remaining chapters of this dissertation. Altogether, the Pear
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laboratory was the first, and to date, the only group to demonstrate an in vivo physiological
relevance for Notch dimerization. Through the utilization of models for T cell and leukemic
maturation, Liu et al. observed that Notch dimerization is not a ubiquitously used process
within downstream Notch target genes. As Arnett et al. also concluded, this signaling
mechanism appears to function on a specific subset of Notch transcriptional targets.
However, led by the examples of Hes5, pTα, and c-Myc, the discovery of cryptic sequencepaired sites may make this group unpredictably large.
Identification of Sequence-Paired Sites
Following the identification, characterization, and physiological relevance of the
first sequence-paired sites

29–31

, the search was on to identify further SPS-driven, Notch

target genes. The identification of a single RBPJ binding site is relatively easy through the
recent advances in sequencing technologies and bioinformatics. Through chromatin
immunoprecipitation with parallel DNA sequencing (ChIP-seq), researchers can
immunoprecipitate DNA-associated proteins (such as RBPJ), purify the DNA fragments,
perform high-throughput sequencing, and through bioinformatics, identify and characterize
DNA binding sites of interest.
This process has been performed several times previously to identify Notchassociated genes, though previous efforts did not attempt to identify any paired RBPJ
binding sites 170,171. While not the primary emphasis of the manuscript, Castel et al. (2013)
33

were the first researchers to attempt to identify RBPJ motifs in tandem. By performing

ChIP-seq on a single RBPJ-immunoprecipitation, they were able to use bioinformatic
screening approaches to find nearby motifs (motifs found with the GimmeMotifs matrix,
172

). Their analysis only found a small pool of tandem RBPJ motifs (26 of 158 high-
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confidence RBPJ sites), but when present, sites were most often in the head-to-head
conformation and 11- to 21-base pairs apart

33

. Of note, most of their identified SPS-

inclusive genes did not contain the ideal 16-nucleotide spacer 29 and instead generally had
a shorter gap distance. Further complicating these findings, the RBPJ motifs were not often
found in the gene’s proximal promoters, but instead found at distal enhancer sites. As this
subset of Notch signaling was not the emphasis of the manuscript, the authors did not
explore this thread any further.
SPS-inclusive promoters and enhancers were further studied by a complementary
approach to ChIP-seq, termed Split DNA adenine methyltransferase Identification
(SpDamID,

34,173

). In this experimental approach, an E. coli DNA adenine

methyltransferase (Dam) is split into two halves and fused to proteins of interest (such as
RBPJ and Notch). When their host proteins interact, the two Dam halves can come back
together into a functional whole protein, resulting in the methylation of nearby adenines
within the DNA sequence 5’-GATC-3’. This creates a recognition site for the restriction
enzyme DpnI (GAmTC), which allows isolated genomic DNA to be restriction enzymetreated (digested), put through adaptor ligation, and finally amplified through ligationmediated PCR. This amplified library pool can then be used as templates for further genespecific PCR reactions or used in genome-wide arrays like microarray hybridization or
high throughput sequencing 34.
While primarily a methods paper, Hass et al. (2015) 34 did validate their approach
through basic analysis of Notch dimerization. SpDamID is capable of finding RBPJ
sequence-paired sites by fusing the two Dam halves onto two NICDs and comparing the
library pool between wild-type and dimerization interface-mutated proteins. Similar to

29
Castel et al., Hass et al. sequenced their dimer-positive library pool, identified the strongest
RBPJ motif, and screened the surrounding nucleotides looking for a paired RBPJ site
(motifs found with the HOMER toolkit,

174

). Their work identified two dimerization-

dependent sites within the NRARP enhancer (gene encodes the Notch Regulated Ankyrin
Repeat Protein, which acts as a negative feedback regulator of NICD signaling), both of
which contained a canonical and cryptic RBPJ binding site. Further, SpDamID and its
motif screening identified an assortment of RBPJ binding motif sequences found within
SPSs, both canonical and cryptic, but the authors failed to connect these sequences to any
gene’s promoters or enhancers.
The most recent attempt at identifying SPS-regulated genes was by the Aster
laboratory, who also used ChIP-seq and a host of bioinformatic tools to analyze their
datasets

35

. First, however, they sought to further characterize the dimeric complex’s

sequence requirements to use these guidelines when sorting through their future ChIP data
sets. To address this question, they developed a fluorescence resonance energy transfer
(FRET)-based assay to quantitatively measure NTC dimerization on a host of DNA
sequences. In their system, two maleimide-derived fluorophores are used and attached to
NTC components through specific cysteine mutations within the ankyrin domain of NICD.
In a FRET assay, one of the fluorophores is excited by an outside source and, if spatially
close (<10 nm, as in their NICD dimerization arrangement), will transfer its energy to an
acceptor fluorophore (creating a donor-acceptor pair), which then itself excites and emits
detectable light at an alternative wavelength. In the absence of NICD dimerization, as in
the case of ankyrin interface mutants or non-cooperating sequence-paired sites, the
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fluorophores are no longer paired resulting in the excitation and emission of just the donor
fluorophore.
Utilization of their FRET-based assay clarified two requirements for NICD
dimerization on sequence-paired sites. First, as previously explored through EMSAs 29,30,
cooperative assembly (and therefore FRET signal) only occurs on DNAs containing spacer
distances of 15 to 17 base pairs. Second, they explored the NTC dimerization on DNA with
consensus or a variety of nonconsensus RBPJ binding sites. They observed that when these
nonconsensus (cryptic) sites were paired as palindromic sequences (the same site at the
forward and reverse locations), they failed to support dimerization. In contrast, when a
nonconsensus site is paired with a consensus site (as in the case of Hes5 or pTα, detailed
previously

30,31

), this arrangement facilitates dimerization
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. Since a wide variety of

nonconsensus sequences were observed to facilitate dimerization, these previous and
current observations indicate that screening for Notch-driven sequence-paired sites is an
exceedingly tall order.
To identify further sequence-paired sites, Severson et al. (2017)

35

reanalyzed

ChIP-seq data they had previously acquired from a T-ALL cell line, CUTLL1 175,176. Their
original ChIP-seq analysis identified dynamic RBPJ/Notch binding sites which are
spatially associated with Notch responsive genes, and nondynamic RBPJ binding sites,
which appeared insensitive to the status of Notch signaling (on or off). The nondynamic
sites were purged from their dataset which was then further analyzed for sequences likely
to support NTC dimerization, through both canonical and cryptic SPSs. They found that of
996 dynamic and high-confidence RBPJ/Notch binding sites, 197 (~20%) of those
contained high-confidence SPSs. Interestingly, while the 16-nucleotide spacer provided the
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best structure for NTC cooperation, there was a roughly equivalent number of sites with
15- to 17- base pair spacers (15 bp, n = 78; 16 bp, n = 60; 17 bp, n = 60, note these don’t
add up to 197 and the authors did not clarify this discrepancy). Finally, as was the case
with monomeric RBPJ sites 175, most SPSs (86%) were found within distal gene enhancers.
With the number of SPS-inclusive genes in CUTLL1 cells in mind, Severson et al.
sought to identify the contribution of NTC dimerization towards gene expression in T-ALL
(using CUTLL1 cells). They performed RNA-seq on cells transduced with either wild-type
or ankyrin mutated (R1984A) N1ICD, and of the 281 genes activated by wild-type N1ICD,
93 of those were not activated by the dimerization-deficient protein. At face value, this data
indicates that about a third of Notch-induced transcription relies on NICD dimerization.
However, a portion of these 281 genes could just be downstream targets of Notch effector
proteins, and not actual targets of NICDs themselves, resulting in the possibility of false
positives. To narrow the focus of this analysis to genes that are directly regulated by Notch
signaling through RBPJ sites in their promoters or enhancers, they referred to the CTCFbounded chromatin domains model of spatial DNA arrangement.
In this model of genome organization, the genome can be split into functional
chromatin domains, divided by insulator DNA elements. These elements prevent
inappropriate interactions between neighboring regions of the genome and effectively act
as blockades for the effects of enhancers. The DNA binding protein CCCTC-binding factor
(CTCF) is a well-characterized insulator-binding protein and plays crucial roles for the
insulator’s barrier function 177–180. Severson et al.’s previous ChIP-seq work 175 suggested
that dynamic RBPJ binding sites within enhancers are most likely to control genes within

32
their same CTCF block, even if those RBPJ sites are closer in sequence to the start site of
another gene that’s within a different CTCF block.
Utilizing this model to rescreen their RNA-seq dataset for direct Notch target genes,
they found that of 107 high-probability, direct Notch-target genes in a T-ALL cell line, 38
of those are NTC dimerization dependent. A list of these genes are available in their online
supplementary data 35 and includes known dimer-dependent genes like Hes1, Hes4, Hes5,
and NRARP, though distinctly, the identified site within the Hes5 enhancer was not the
cryptic SPS identified by Arnett et al. Further, this screen does not identify the previously
discussed pTα, c-Myc, FJX1, SYT14, or CUL1 genes. While the Severson et al.
dimerization-dependent gene list is likely accurate, these discrepancies suggest that this is
not a complete story. The absence of FJX1, SYT14, and CUL1 from the dimerizationdependent list may be slightly ignored: their SPS sites were only explored in vitro through
EMSA analysis and may not be even transcribed in T-ALL cell lines

30

. However, their

bioinformatic screen not identifying the cryptic SPSs within pTα, c-Myc, and Hes5 can’t
be so easily dismissed. pTα (also named PTCRA) and c-Myc contain a bona fide cryptic
sequence-paired site within their enhancers, were significantly controlled by NTC
dimerization and were observed in another T-ALL cell line, T6E cells

31,169,181,182

. The

cryptic SPS control of the Hes5 promoter was thoroughly explored as well, though its
activation was tested in an alternative cell line. The absence of these three genes on this
list may be attributed to some differences in cell line genomics (despite pTα and c-Myc
being explored in the same disease model), their promoters and enhancers may contain a
variety of monomeric and SPS sites which could confound these screen results, or most
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troubling, cryptic sequence-paired sites may not be sufficiently identified through Severson
et al.’s bioinformatic approach.
In summary, Severson et al. developed a technique to quantitate and compare NTC
dimer formation on alternative sequence-paired sites and transitioned these findings into a
search for both canonical and cryptic SPSs from ChIP-seq data sets. They identified a
variety of dimer-responsive elements active in T-ALL cell lines, and are the first group to
connect these elements, most often within enhancers, to their effector genes. However, just
how exhaustive their screens are, remains to be seen. Their bioinformatic tools are likely
proficient at identifying both monomeric and canonical sequence-paired sites involved in
T-ALL development. That said, exemplified by the absence of the cryptic SPS genes pTα,
c-Myc, and Hes5 from their list, their approach is not perfect and may need remodeling.
Altogether, bioinformatic tools and techniques have been developed to identify a wide
variety of RBPJ/Notch binding sites within the genome. While using ChIP-based
approaches to identify single RBPJ binding sites has been well studied and developed,
taking those same data sets and reanalyzing for paired-sites is still in its infancy. Hass et
al. and Severson et al. both offer tools and approaches to screen and identify active
sequence-paired sites, and these techniques should be transferrable to other Notchregulated models, such as within vascular development.
An Alternative Dimerization Model
Beyond the ankyrin-mediated dimerization model, there exists one other case of
Notch dimerization. In a report from 2002, back from before the first crystal structures for
the Notch ternary complex were solved, the Capobianco lab isolated stable Notch nuclear
complexes from Notch-induced neoplasmic cells and confirmed its protein components
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(RBPJ/NICD/MAML), among other unidentified members

183

. They also made note of

another NICD complex, smaller than the ternary complex and with substoichiometric
amounts of MAML and RBPJ, found within the cytoplasm. In a follow-up report nearly a
decade later, the Capobianco lab identified it as a Notch dimer and a precursor to the
complete ternary complex 32.
Using recombinant proteins from various host sources (bacterial/insect/mammalian
cells), performing both in vitro and within cell line experiments, the authors were able to
recreate and identify their previous cytoplasmic Notch complex. They found that the
complex starts with a simple homodimer between two N1ICDs; no other proteins were
necessary for this interaction. Distinctly, this interaction was ankyrin-domain independent.
This homodimer instead utilizes sections just outside of the NICD RAM and TAD
domains, where the RAM-interacting portion binds to a section near the TAD domain of
the partner protein, resulting in an antiparallel arrangement between the bound proteins.
For clarity, I’ll refer to this arrangement in the rest of this dissertation as the ‘antiparallel
model’ since the Capobianco lab only referred to it as an NICD multimer. Vasquez-Del
Carpio et al. (2011)
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found that this initial antiparallel complex then starts the stepwise

assembly of the nuclear ternary complex.
Through a strenuous series of mutations and domain deletions, Vasquez-Del Carpio
et al. suggested a model for the assembly of the Notch transcriptional activation complex.
First, antiparallel Notch homodimers form in the cytoplasm and then recruit and complex
with Ski-interacting protein (Skip), a transcriptional coactivator, through the NICD ankyrin
domain. Skip was originally implicated in the Notch signaling pathway through its binding
to DNA-bound RBPJ, where the SMRT/HDAC corepressor complex and active NICDs
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compete for Skip/RBPJ binding 184. This model was later refined to include Skip’s role in
transcriptional activation and recruitment of other transcriptional machinery, though the
exact mechanism was not elucidated 137,185. Vasquez-Del Carpio et al. observed that, in the
complex with an NICD homodimer, Skip and NICDs create a docking site for MAML1,
forming a preactivated complex. At some point, which is not clarified in the manuscript,
the complex must translocate to the nucleus as the next step is to interact with RBPJ.
Beyond the canonical contacts with the NICD’s RAM domain, RBPJ has also been
described as interacting with the NICD’s ankyrin domain (briefly reviewed and studied in
Wilson & Kovall, (2006); Nam et al., (2006) 117,126). The NTC complex finally forms by
an RBPJ-mediated displacement of Skip from the NICD ankyrin domain, where RBPJ
competes for the same contact region

32

. They also hypothesize that the Skip/RBPJ

exchange removes the corepressor complexes from RBPJ, though this mechanism was not
further explored. Similarly, the preactivation complex interacting with RBPJ was thought
to displace the partner NICD in the antiparallel model, which was then free to restart this
stepwise assembly, though its fate was not investigated.
There are a few important clarifications between the antiparallel and ankyrinmediated NICD dimerization models that need to be mentioned. First and foremost, as it
currently stands, the antiparallel model does not have any direct implications in dimerdependent signaling. This model posits that dimerization is completely through the RAM
and TAD domains; the ankyrin domain and any mutations (R1984A) did not alter their
observed dimerization 32. Instead, the antiparallel model may have broader impacts on all
Notch signaling targets: in their work, NICDs that could not complete the first antiparallel
assembly step (Notch homodimerization) were incapable of activating downstream Notch
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reporter assays 32. Second, their reporter assays were only studied with synthetic, dimerindependent promoters. All NICD domain mutations utilized were only applied on headto-tail RBPJ binding site constructs, and therefore their observed downstream application
may not apply to dimer-dependent Notch signaling. This is of particular interest since the
mechanism behind the loss of the dimerized NICD partner and its fate was not explored;
what if the lost protein could be instead integrated into a secondary RBPJ binding site
within a sequence-paired site? Third, the antiparallel model may only apply to Notch1
signaling. In contrast to the highly conserved ankyrin-mediated dimerization interface,
these sections of the RAM and TAD domains are not well conserved across the four
mammalian Notch proteins. Further, while the other Notch proteins (Notch2-4) were only
minimally studied in the ankyrin-mediated model 29, Vasquez-Del Carpio et al. did not look
for dimerization within the other Notch proteins, opting to just study Notch1.
In summary, antiparallel NICD dimerization through sites near the RAM and TAD
domains appears to be an important first step for NTC assembly and transcriptional
activation. Importantly, the two Notch dimerization models are not mutually exclusive.
While Vasquez-Del Carpio et al. hypothesized that the second NICD leaves the completed
NTC complex, it’s also possible that it gets integrated into a secondary complex or doesn’t
leave at all. To be explored in-depth in the next section, all of the previously discussed
manuscripts concerning the ankyrin-mediated dimerization interface have never explored
the alternative binding sites found within the antiparallel model. Unfortunately, the
dimerization crystal structure solved by the Blacklow laboratory 30 did not include these
RAM and TAD sites within their purified NICD. While this was likely due to the size
restrictions of X-ray crystallography or perhaps just because of the expression constructs
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they had on-hand, regardless, it’s still completely unknown if or how the RAM and TAD
domains interact in full-length, ankyrin-dimerized, NICDs.
Outstanding Questions
While the field of Notch intracellular domain dimerization has moved steadily
forward since it was first described in 2007, the vanguard has left behind concerning gaps
in knowledge and open questions in its wake. Many of these gaps can be attributed to two
assumptions made in the first dimerization manuscript which have not been addressed in
any of the field’s research since. The Blacklow laboratory assumed that 1) the other
members of the Notch family dimerize the same way as Notch1, and 2) the ankyrin domain
is the only site that mediates NICD dimerization. These assumptions, combined with
various other observations and experimental weaknesses, led us to ask three outstanding
questions which will be addressed and explored within Chapters 2 and 3 of this dissertation.
The ensuing questions will be followed by a brief explanation, our research objective, and
then concluded by a more thorough explanation and justification.
Question 1: Are all members of the Notch family capable of homodimerization? Would
this extend to heterodimerization?
In their original dimerization manuscript

29

, the Blacklow laboratory identified

several points of contact between two Notch1 ICD ankyrin domains by using two mirrored
NTC complexes on the Hes1 SPS. Mutation of these N1ICD residues prevents Notchdriven activation of SPS-inclusive genes (Hes1), resulting in a new category of Notch
target genes; those that are dimer-dependent. They further note that these contact points
are conserved across the Notch family members, indicating that dimerization is likely an
evolutionarily conserved function. However, their manuscript and all follow-up studies
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since then have lacked evidence demonstrating that this dimerization mechanism is
consistent throughout the four mammalian Notch receptors.
Objective 1: To explore which NICD dimerization iterations occur within a protein overexpression, cell culture model.
The single piece of support for dimerization outside Notch1 is through an EMSA
of 1-1, 2-2, 3-3, and 4-4 homodimers 29. While this experiment did demonstrate that two
NTCs were loading on the Hes1 SPS, two important controls were missing before we can
claim that they dimerize. Beyond N1ICD, the authors did not perform any mutagenesis on
the other Notch family members. Without this negative control for dimerization, we
shouldn’t assume that the other Notch family members contain an identical dimerization
interface, or even dimerize at all. While the contact amino acids involved are conserved,
there are no crystal structures of the ankyrin domains for Notch2-4 to refer to for structural
comparisons. Further, there are other variations within the ankyrin domain (including the
interface), RAM domain, and massive differences in the C-terminal region which could all
change the small window necessary for ankyrin-ankyrin cooperativity. The second control
that was left unaddressed is at the transcriptional level. While Nam et al. demonstrated that
N1ICD dimerization mutants cannot activate a Hes1 reporter assay, they did not check if
the other suspected Notch family homodimers are in this same category. We know that all
NICDs can activate this type of promoter element 28, so even if this activation is through
dimerization, we should not assume that it plays an equivalent role for each Notch protein.
The Blacklow laboratory further proposed that since each Notch protein could
dimerize, and the interface is conserved among them, then it’s feasible that NICD
heterodimers could form too. This possibility would depend on cellular contexts, requiring
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expression and activation of multiple Notch proteins in the same cell at the same time. This
situation occurs in a variety of cell types and within Notch models, such as in T-ALL
development 186–188 or within vascular biology 70,189,190. Regardless, even with the existence
of these model systems, the hetero- or homodimerization of NICDs outside of Notch1 has
not been explored to date.
Question 2: How do the RAM and C-terminal domains affect NICD dimerization? Does
the antiparallel model interact with the ankyrin-mediated dimerization model, or are they
independent systems?
When analyzing the Notch crystal structures discussed previously

30,126

, it’s

important to keep in mind that these complexes were built using partial proteins. These
NTC crystals are composed of the canonical SPS from Hes1, most of an RBPJ protein, a
small fragment of MAML1, and just the ankyrin domain of Notch1. While these protein
sections are sufficient for complex assembly, and the identified ankyrin-ankyrin contacts
have transcriptional implications in a dimerization-dependent system, it’s presumptuous to
assume that this partial model correctly represents a dimerized transcriptional complex for
all Notch family members.
Objective 2: To explore the roles the RAM and C-terminal domains may have in NICD
dimerization, particularly emphasizing if these less-conserved regions alter the
dimerization abilities of the different Notch proteins.
These crystal structures are potentially poor representatives of a dimerized system
because of the missing domains of Notch1. In a canonical system, the RAM domain drives
the initial recruitment of an NICD to RBPJ through its BTD domain, and then the NICD
ankyrin domain docks with the other domains of RBPJ, RHR-N and -C, which is
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hypothesized to be a reversible process. In combination with the RHR domains of RBPJ
and the ankyrin domain of NICD, a segment of MAML1 nestles into a newly formed
groove derived from both proteins, which is thought to ‘lock’ the complex together

126

.

Since the RAM domain is missing in the dimerized NTC crystals, it’s difficult to say for
sure exactly how the ankyrin domain will arrange onto RBPJ and therefore interact with a
partner complex. This isn’t the most troubling observation, however, since Notch variants
lacking the RAM domain can still activate transcription, indicating that a ternary complex
can still form independently of the RAM domain

53,183

. An even more concerning

possibility, however, can be derived from an observation Arnett et al. made of their
dimerized NTC crystal. They note that for the ankyrin-ankyrin contacts to come together,
the DNA had to go through substantial bending and untwisting 30. Again, this observation
was made from a dimerized NTC complex built without the NICD RAM domain. If this
domain was intact, would an increased number of contacts between NICD and RBPJ result
in more or less flexibility of the larger complex? If that’s the case, would a change in
flexibility alter the ideal number of bases between an SPS?
These questions are partially addressed, albeit indirectly, in these pioneer
manuscripts. While the Blacklow laboratory used just the ankyrin domain for their crystals,
they opted to use the RAM and ankyrin domain (RAMANK) for their in vitro EMSA
experiments. Beyond supporting canonical dimerization, these EMSAs demonstrate that
cooperating NTCs can also form on cryptic SPSs 30,31,169, an observation that will become
pertinent later in this dissertation. Ultimately, these experiments produce the same
guidelines for dimerization that the crystal structure does and indicates the RAM domain
likely has a neutral effect on cooperative assembly. Distinctively, however, neither the
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crystal structures nor EMSAs include the NICD’s substantially large and highly divergent
C-terminal region.
Containing at least two well-accepted domains (TAD/PEST) and littered with less
characterized regions, Notch’s C-terminus is the least studied part of the Notch protein and
is the most variable between the four family members. While each Notch protein contains
a PEST domain, earmarked by its roles in protein degradation, the presence and
composition of a TAD domain is variable among the Notch family members. Besides
necessary assisting roles in transcriptional activation, any structural roles or interactions of
the CTD domains within the NTC complex are unknown. Further, the Notch2 TAD
deviates heavily from the Notch1 TAD (about 45% overall identity, 191), while Notch3 and
4 are not considered to contain a TAD at all, and instead, their truncated C-termini are
entirely uncharacterized (except for their PEST domain).
These C-terminal uncharacterized regions and the RAM domain contain the
alternative dimerization sites used in the anti-parallel dimerization model proposed by the
Capobianco laboratory. While the N-terminal location would be present within the
Blacklow laboratory’s EMSAs, the antiparallel model has the N-terminal site strictly
interacting with a region just N-terminus of the TAD, which is lacking in their in vitro
experiments. While the Capobianco lab hypothesized that the antiparallel dimerized
NICDs resolve into monomers on DNA, this theory was only derived from their utilization
of reporter constructs with monomeric RBPJ binding sites.
This situation culminates in an interesting possibility and relates back to our
original question: perhaps on sequence-paired sites, the N- and C-termini remain associated
within their cooperating NTCs. Retaining these interactions would require physical access
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to these regions all while assembled within a dimerized NTC, and unfortunately, the
substantial crystal structures needed for this conformational information have yet to be
resolved. However, while this possibility has not been specifically addressed, we may be
able to glean insight from other Notch crystal structures. There are two crystal structures
of a Notch ternary complex which include the RAM domain within the purified protein.
The first was of the RAMANK domain of the C. elegans Notch protein (Lin-12) (PDB ID:
2FO1,

117

), and the second was of human Notch1 RAMANK (PDB ID: 6PY8,

192

).

Importantly, both protein crystals resolved the same way: while the specific RBPJ-RAM
interactions were structured and resolved, the region containing the proposed N-terminal
dimerization region did not have electron density, indicating a disordered, presumably
unstructured region. Since this region is within an open interface within the NTC and not
already used in an internal interaction, it’s a possibility that the N-terminal dimerization
site is capable of protein-protein interactions within a dimerized complex.
Structural information regarding the other component of the antiparallel interaction,
the C-terminal site, isn’t as convenient. There are no crystal structures of the Notch Cterminus, within an assembled ternary complex or even by itself, so trying to predict if this
region interacts with the N-terminus would likely be overambitious. Still, a variety of
reports have demonstrated its importance for NICD-induced gene transcription of known
dimerization-dependent genes

52,54,55

. Further, an in vitro analysis was performed which

compared NTC complex assembly efficiency between wild-type N1ICD and one that’s
missing the TAD domain, including the suspected C-terminus dimerization site. Nuclear
lysates were collected and allowed to assemble on an oligonucleotide of the Hes1 SPS and
demonstrated that the presence of the TAD is important for the proper assembly of a ternary
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complex 54. The authors predicted that the simplest explanation for this behavior is that the
TAD participates in intermolecular contacts to stabilize the complex, or perhaps other
cofactors interact with the TAD and promote ternary complex assembly

54

. Importantly,

either of these two possibilities could be fulfilled by N-/C-terminal interactions as in the
antiparallel model.
In combination with hindsight, this evidence suggests that not including the RAM
and C-terminal domains in the original characterization assays was a potential misstep.
While it appears that in a reduced system (crystallization, EMSAs) the NICD ankyrin
domain is sufficient for dimerization, in an in vivo system, dimerization may be much more
involved. Further, these additional interactions may explain how dimerization results in its
profound transcriptional activation or how cooperative loading works at cryptic sequencepaired sites. These possibilities remain to be explored and these findings may drastically
affect the model on how NICD dimerization functions across the Notch family.
Question 3: What are the limitations to dimerization on sequence-paired sites? By
differing in size and presence or absence of domains, do the other Notch family members
have alternative preferences?
The intracellular domain dimerization of Notch1 appears to adhere to strict
requirements, where cooperative loading only occurs when the gap distance between RBPJ
binding sites is 15-17 base pairs

29,30,35

. While the optimally spaced gap distance appears

to be 16 base pairs for Notch1 ICD, Severson et al. found that there was roughly equivalent
SPS representation between the three possibilities (15-17 nucleotides), where the 15nucleotide gap was the most common arrangement

35

. Further, a ChIP-seq screen for

sequence-paired sites by Castel et al. identified 22 genes with paired RBPJ motifs with
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gaps that range from 11-21 base pairs

33

, though the dimerization dependence of these

genes was not explored in that manuscript nor elsewhere. Altogether, this argues that the
presence of non-optimal and noncanonical sequence-paired sites exist and they may be
more abundant than initially thought.
Objective 3: To examine these alternative SPS gap distances and identify if the Notch
family members have preferential target arrangements.
Beyond minor variations in the SPS gap distances, the initial characterization
studies may have forgotten an important property of their sequence-paired site DNA
oligonucleotides: in its standard form, DNA is in a double helix with orientation and spatial
implications. The crystal structure and FRET assays dictate that a 16-nucleotide spacer
allows for the lowest degree of untwisting and bending of the DNA between the two NTCs
so that they are optimally facing each other. Since DNA requires about 10 nucleotides to
complete a full rotation, consider how the secondary site rotates around the DNA as the
SPS gap distance increases or decreases. They originally tested up to ± 5 bp (11-21 bp),
meaning that the secondary NTC site, despite still being in the same orientation, would
slowly rotate around the DNA as the gap distance changes. Therefore, in their experiments,
it’s logical that the contacts would break as the size increases (substantial decreases would
lead to spatial overlaps too) and no cooperative assembly was observed at their most
extreme distances tested.
It’s possible, however, that the NTC complexes could rejoin once more as the NTC
rotates around the DNA even further. We hypothesized that an additional five nucleotides
would be required to complete a full rotation around the DNA to make the two NTC
complexes on the same side of the DNA again. This new gap distance, a total of 26
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nucleotides, may allow for long-distance cooperative assembly and therefore dimerizationinduced signaling. This logic could be taken to extremes and be applied to previously
recognized monomeric sites, but as the DNA gap distance increases, so does the spatial
distance, which requires even further kinking or looping of the DNA. Thus far, the potential
of these larger gap distances tolerating cooperative assembly has been left unaddressed;
both through in vitro analysis and bioinformatic screening for sequence-paired sites.
With these possibilities in mind, one question that arises is: What’s the limit of SPS
gap lengths that are constructive for cooperative assembly and result in dimerizationinduced signaling? Considering that the original characterization studies just used partial
proteins and these experiments were performed in vitro, we should question if the original
guidelines transfer to more in vivo models. Perhaps some cellular conditions would allow
these smaller or larger gap-distanced sites to act as locations for dimerization, or it’s a
possibility that the alternative-distanced SPSs Castel et al. identified were just falsepositives. If they do exist and function as sites for dimerization, one intriguing prospect is
through its utilization of other members of the Notch family. If all Notch family members
can homodimerize, their slightly different RAM and ankyrin domains, and perhaps their
substantially different C-termini, may dictate alternative idyllic gap distances.
This mechanism would have substantial impacts on Notch signaling. As it stands,
all active NICDs (Notch1-4) bind to the same RBPJ protein which interacts with the same
consensus site to drive gene transcription

161

. At this most rudimentary level of

understanding, it implies that all Notch proteins result in the same signaling outcomes. This
is not the case, however, thanks to a wide variety of NICD differences and modifications,
protein recruitment and cooperativity, and various cellular contexts. Another possible
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mechanism for Notch-family control and specification is if they deviate in their preferred
SPS gap distances, introducing a method for gene-specific Notch targeting. In a
hypothetical situation, for example, if Notch4 homodimers prefer a 14-nucleotide gap
distance whereas the other Notch family members prefer alternative distances, then only
Notch4 would be able transcriptionally activate Mdm1, a gene with a suspected 14nucleotide SPS detected in the screen by Castel et al. This kind of specification would
prove beneficial in the Notch signaling system, where cells generally express multiple
Notch receptor family members and their ligand-induced activation is generally nonspecific 193–197. Consequently, an SPS-specific Notch targeting system would grant cells an
additional layer of control over their Notch functions. Therefore, the possibility of
alternative preferences beyond those set by Notch1 is worth investigating.
Dissertation Summary and Future Directions
The following chapters of this dissertation represent two manuscripts which sought
to address the aforementioned concerns and questions. Our overarching goal was to take
these questions and answer them outside of an in vitro context, attempting to get as close
to endogenous interactions as possible, given the tools and methodologies available to our
laboratory. While the work performed here is not within a perfect in vivo context, it should
act as a steppingstone for further Notch dimerization research in our lab and provide
direction for the field’s future.
Chapter 2 – Analysis of Notch Family Dimerization
Chapter 2 identifies that all Notch homodimer and heterodimer iterations (1-2, 1-3,
2-2, 2-3, etc.) can exist within cells, though they were at varying abundances. Further,
NICD dimerization with an N4ICD partner led to, by far, the most abundant interactions.
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Herein, we also implicated a dimerization-responsive region within the Notch protein’s Cterminal region, in contrast to the NICD’s N-terminus which acted equivalently. Our
methodology used here was primarily co-immunoprecipitations of overexpressed, peptide
tagged NICDs, which is a step towards in vivo work that has rarely been taken in the Notch
dimer field. However, this technique cannot discriminate between the two dimerization
models (ankyrin versus anti-parallel), thus we are not able to conclude if, when, or where
these two dimerization states exist.
Chapter 3 – Dimerization within Transcriptional Systems
Chapter 3 found that all members of the Notch family adhere to the strict
dimerization guidelines set by Notch1; the only SPS gap distances that elicited signal were
of 15-17 nucleotides. Further, in our minimalistic dimerization reporter assay, a cryptic
sequence-paired site (Hes5) was unresponsive to dimerization, contrasting the
dimerization-dependence seen when using the full-length promoter.
In this chapter, we wanted to specifically examine the transcriptional outcomes of
NICD dimerization, and further manipulate and change the sequence-paired sites in the
most basic ways to push this signaling system to its limit. When first using the dimerdependent reporters that previous studies utilized, we noted that these assays were likely
too generic for our purpose. They contain large segments of the promoters of dimerdependent genes, such as Hes1 and Hes5, and any effects of small manipulations of these
promoters would be muted behind the roles of other transcription factors and regulatory
systems. Thus, in this chapter, we developed a new type of reporter assay to specifically
study the roles and limitations of dimerization-mediated transcriptional activation. These
novel reporter assays consist of the sequence-paired site found within dimer-dependent

48
genes with its few surrounding nucleotides, and this minimalized system is sufficient to
drive transcription of a luciferase gene, thus resulting in a minimalistic luciferase reporter
assay.
These reporter assays demonstrated that while canonical sequence-paired sites
(Hes1) are sufficient for dimerization and further transcriptional activation, the same
cannot be said for cryptic sequence-paired sites (Hes5). Distinctly, while previous reports
suggest that a cryptic SPS oligonucleotide can cooperatively load NTCs in vitro

30,31,169

,

our report suggests that this minimalized segment either does not assemble complexes
within cells or does assemble but is insufficient for robust transcriptional activation. We
were then able to take these functioning SPS-luciferase reporters and manipulate their gap
distances to observe any differential preferences of the Notch family members. Contrary
to our original hypothesis, each Notch family member followed the requirements set by
Notch1 in the original landmark studies; only SPSs with a gap of 15-17 nucleotides were
capable of dimerization-induced activation. Therefore, the alternative gap distances
identified by Castel et al. and any other larger gap distances (>21 bp) are likely just
coincidentally similar to traditional SPSs and are not activated through canonical NICD
dimerization.
Future Directions
The work described here has filled-in some potentially troubling holes the vanguard
left behind during their initial surge of research activity and has further solidified the
foundation for future work to build upon. However, as with all sciences, the recovery of
some holes has uncovered the possibility of others. The mystery surrounding cryptic SPS
activation, the troubles of identifying genes controlled through SPSs, and further
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identification of Notch dimer-dependent models are all worthwhile avenues of future
research.
Given the apparent abundance of cryptic SPS-driven genes, future work should aim
to identify what dictates their transcriptional activity compared to canonical SPSs. We and
others have shown that the complete Hes5 reporter is dimer-dependent, yet when its cryptic
SPS was isolated out in our studies, this minimalized reporter lost its dimer-dependence.
We propose two possible explanations that would need further validation. First, it’s a
possibility that while cryptic SPSs can load two NTC complexes in a purified, high
stoichiometry system (EMSAs), this may not occur in a natural cell state without the aid
of cis-regulatory elements or other co-transcription factors. Alternatively, like in others’
EMSAs, our Hes5(SPS) luciferase reporter may be loading cooperating complexes but is
lacking another promoter element that transitions dimerization into transcriptional output.
Both explanations lead to a single experimental resolution: expand the Hes5(SPS) into the
surrounding natural promoter area in an attempt to find a cis-regulating element. This
element could then be screened for and identified in other known cryptic SPS genes to find
some shared co-transcription factor regulating Notch dimerization.
In addition to screening for other cis-elements, perhaps more importantly, the Notch
dimerization field needs to improve their methodology of finding genes regulated through
sequence-paired sites. The current standard of performing ChIP-seq after a single round of
purification and screening those targets for secondary RBPJ binding sites has left much to
be desired. Our previous discussions on studies which utilized ChIP-seq screening pointed
out that the screens used either have holes too specific which miss many cryptic sequencepaired sites or have holes too wide which identify genes that contain alternatively spaced
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SPSs or ones with RBPJ motifs in the wrong orientation. Further, this dissertation
demonstrates that any alternatively spaced SPSs are not constructive for dimerization, and
thus should be purged from future ChIP-seq attempts. One resolution to this problem,
which we have shown is experimentally feasible, is to perform ChIP-seq on targets that
went through two rounds of purification. Instead of immunoprecipitating the standard
RBPJ, future attempts should target differentially tagged NICDs (or heterodimers) for
double selection and then perform ChIP-seq on this more specific pool. While a more
stringent approach, it should identify active SPS motifs specifically regulated through
dimerization.
Along with identifying further SPS-driven genes, it’s necessary to do this within
the context of multiple Notch-regulated cell systems. With expanded knowledge that all
Notch proteins are capable of dimerization, it’s pertinent to see how this can be applied to
Notch models for development and disease. While a good starting point has been the role
of Notch dimerization in the development of T cell acute lymphoblastic leukemia, this is
still a cancer model of constitutively active Notch signaling. Future work should expand
into other Notch models such as within neurogenesis

198

or the vasculature

199,200

, with a

particular interest in systems that utilize multiple Notch receptors to further explore the
potential of Notch heterodimerization.
With further identification of dimerization-induced Notch target genes, this system
could provide an interesting opportunity for Notch therapeutics. One potential therapeutic
approach for leukemia and other cancers, for example, is through treatment with γsecretase inhibitors. These inhibitors prevent Notch S3/S4 proteolysis through interactions
with the γ-secretase complex, thereby stopping Notch signaling. However, these inhibitors
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have been disappointing in clinical trials because of dose-limiting and on-target toxicities
167,201

. Notch dimerization presents a new target for therapeutic intervention; the

dimerization interface. As previously proposed by both the Blacklow and Pear laboratories,
specifically targeting the dimerization interface with a small molecule inhibitor, abrogating
just a single facet of Notch signaling, may have more favorable toxicity profiles than other
pan-Notch inhibitors. Efficacy of this method of inhibition and the development of these
dimerization-inhibitors remains to be explored.
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Abstract
Notch signaling is universally conserved in metazoans where it is important for a
wide variety of both normal and abnormal physiology. All four mammalian Notch
receptors are activated by interactions with Notch ligands present on adjacent cells in the
cellular microenvironment and trigger the release of Notch intracellular domains (NICDs)
that translocate to the nucleus and stimulate transcription from Notch sensitive promoters.
All NICDs contain highly conserved ankyrin domains which are important for NICD
homodimerization and are flanked by more divergent N- and C-termini. Due to the highly
conserved nature of Notch ankyrin domains, we hypothesized that NICDs may also engage
in heterodimerization. Using a co-immunoprecipitation approach, we show that all NICDs
engage in both homodimeric and heterodimeric interactions. The Notch4 ICD (N4ICD)
demonstrated the greatest capacity for dimerization. Interestingly, ankyrin domains were
not necessary for co-immunoprecipitation. Instead, a 50-amino acid segment immediately
C-terminus of the Notch4 ankyrin domain was necessary and sufficient for strong
dimerization. Finally, chromatin-IP confirmed that at least a fraction of heterodimers
formed on DNA.

Collectively, these results confirm that NICDs can engage in

heterodimeric complexes with other NICDs and suggest a mechanism by which Notch
signaling may be diversified through NICD heterodimeric interactions.
Introduction
The Notch signal transduction system is an ancient cell-cell communication
mechanism that is conserved in essentially all multicellular animals

1,3

. Under normal

conditions, Notch serves a wide variety of functions such as development, vascular
biology, and immune function 202. In contrast, dysregulation of Notch is linked to a variety
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of diseases 202. A clearer understanding of Notch signaling will provide new insights into
the diverse processes governed by Notch.
There are four individual Notch receptors (Notch 1-4) present in mammalian
genomes. Notch1 and Notch2 are highly similar molecules while Notch3 is significantly
different, and Notch4 is the most divergent compared to the other Notches

203

. All Notch

receptors are thought to be activated by the same mechanism involving juxtracrine
interactions between adjacent cells when a Notch ligand on one cell is presented to a Notch
receptor on a neighboring cell. Following ligand-receptor interaction, endocytosis of the
Notch ligand provides ~4-12 pN of force

204

which physically separates the Notch

receptor’s extracellular domain at the S1 cleavage site thus priming the molecule for
subsequent cleavage at the S2, then S3 cleavage sites (reviewed in Kadesch, (2004)

205

).

The solubilized cytoplasmic S3 fragments (Notch intracellular domain, NICD) of all Notch
receptors then translocate to the nucleus and participate in a tripartite co-transcriptional
complex with the DNA binding protein and the transcriptional activator MAML

18,26

.

interacts with an 8 bp-optimized sequence (i.e. TP-1 elements) on the DNA 17, and these
sequences can be arranged as monomers, or in head-to-tail (HT), tail-to-tail (TT), or headto-head (HH) orientations also known as sequence-paired sites (SPS).
Experimental evidence from EMSA and crystallography studies have shown that
NICD tripartite complexes can form HH homodimers on SPS sites and that HH
dimerization is important for transcriptional activation of SPS sites

19,24,28–30

. NICD

dimerization is thought to occur between the ankyrin domains of interacting NICD
molecules and both EMSA and crystallographic studies have confirmed the importance of
ankyrin domains in NICD dimerization and transcription from sequence paired sites

29,30

.
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The importance of NICD dimerization through ankyrin interactions is illustrated by the
observations of Liu et al, who found that NICD dimerization is required for Notch induced
leukemogenesis and T-cell development

31

. Sequences in the more divergent N- and C-

termini of Notch receptors have also been implicated in NICD homo-dimerization although
this is less well understood 32. Given the high degree of conservation within the ankyrin
domains of all four mammalian Notch receptors, a long-outstanding question is whether or
not different NICD molecules can engage in both homodimeric as well as heterodimeric
complexes.
The goal of this investigation was to test the hypothesis that the N1-4ICD molecules
can engage in heterodimeric interactions. Using an immunoprecipitation approach, we
were able to confirm that all NICDs interact in both homo- and heterodimeric complexes.
Moreover, we found that the N4ICD was unique in that it demonstrated the strongest homoand heterodimeric interactions. Interestingly, ankyrin domains were not important for the
unique behavior of Notch4. Instead, we determined that a region of the Notch4 C-terminus,
directly downstream of the ankyrin domain, was responsible for mediating strong
interactions with other NICDs.
Materials and Methods
Cell Culture
HEK293T cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 10% equafetal (Atlas Biologicals) and 1x penicillin-streptomycin
solution. Cells were grown in 10 cm plates and passaged at 80-90% confluence.
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Plasmids and Plasmid Mutagenesis
The FLAG-NICD constructs were all gifts from Raphael Kopan

28

and acquired

from Addgene. N1ICD (Addgene #20183), N2ICD (#20184), N3ICD (#20185), and
N4ICD (#20186) all have an N-terminal 3xFLAG tag and code for the transcriptionally
active, intracellular domain of the mouse Notch proteins. The NICD coding regions were
then subcloned into pKH3 (#12555), a gift from Ian Macara 206 to add a C-terminal 3xHA
tag as well as into pcDNA3.1/MYC-His (Invitrogen) to add a C-terminal MYC-His tag.
The C-terminally truncated N1ICD-MYC construct was given to us by Raphael Kopan 23
(#41730) and encodes for the mouse N1ICD from V1744 to S2184.
The mouse Notch ankyrin domain mutants were created by aligning the human and
mouse N1ICD to find the equivalent arginine involved in N1ICD dimerization

29,63

.

Afterward, the mouse NICDs were aligned to find the equivalent arginines across the
mouse Notches. N1ICD (R1974A), N2ICD (R1934A), N3ICD (R1896A), and N4ICD
(R1685A) mutants were all created through site-directed mutagenesis in each taggedvariation of the NICD (FLAG/HA/MYC).
The N1ICD-N4ICD domain-swapped proteins were created through Gibson
assembly using the FLAG-tagged variants. The equivalent mouse ankyrin domain was
found using the previously outlined human Notches

191

and centered our swaps around

these sites. Therefore, we have three NICD regions to swap between each other; the Nterminus region (N1: V1744-D1863, N4: V1463-D1571), the ankyrin domain (N1: V1864S2111, N4: V1572-A1826), and the C-terminus region (N1: P2112-K2531, N4: H1827N1964).
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The N4ICD C-terminus truncations were created through Gibson assembly. The
N4ICD C-terminus consists of 138 amino acids (everything C-terminus of the ankyrin
domain), which we truncated into nearly equal portions. The first truncation was of 13
amino acids (-13 V1463-H1951) and from there we cut off 25 amino acids at a time (-38 A1926, -63 -R1901, -88 -C1876, -113 -G1851, and -138 -A1826).
For the transcriptional reporter assays, Hes5-Luc (#41724) was a gift from
Ryoichiro Kageyama and Raphael Kopan. This luciferase reporter contains portions of the
mouse Hes5 promoter and includes several RBPJ binding sites to report the activity of
Notch signaling. The Hes4-luc reporter (-139 to -9) was cloned by PCR amplification of
the ChIP isolated Hes4 DNA shown in figure 2.8. This PCR fragment was cloned into
pGL3-basic (Promega) with 5’Kpn1 and 3’SacI sites. The CMV-β-gal plasmid was
originally from Clonetech.
All primers used for vector cloning and NICD mutagenesis can be found in
Supplementary Table 2.1.
Immunoprecipitations
Cells were plated into 6-well plates at a density of 300,000 cells/well. The following
day, cells were transfected with polyethylenimine (PEI, Polysciences) at a ratio of 5 μg PEI
for every 1 μg plasmid DNA. Since the various NICD molecules are expressed at different
levels in cells, we transfected varying amounts of NICD expression construct to standardize
protein concentrations in CO-IPs as follows (750ng N1ICD, 500ng N2ICD, 500ng N3ICD,
250ng N4ICD).

Forty-eight hours after transfection, cell lysates were prepared for

immunoprecipitations and performed as previously described 157.
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Western Blotting
Prepared protein lysates and CO-IP samples were separated through SDS-PAGE
on polyacrylamide gels. Samples were then blotted onto nitrocellulose membranes and
blocked in TBS-T (140 mM NaCl, 25 mM Tris-HCl, pH 7.4, 0.1% Tween-20) with 5%
bovine serum albumin. Membranes were incubated with primary antibody (1:500; MYC,
1:1000; FLAG, 1:2000; HA) overnight on a rotator at 4oC. Following incubation,
membranes were washed 3 x 10 minutes in TBS-T and then incubated with a secondary
antibody solution, composed of horseradish peroxidase-conjugated secondary antibodies
at a concentration of 1:10,000. Membranes were then washed again 3 x 10 minutes in TBST and proteins were detected through enhanced chemiluminescence.
Antibodies
For western blotting, primary antibodies against FLAG(DYKDDDDK)-tag
(D6W5B) were purchased from Cell Signaling Technology, while antibodies against
HA(YPYDVPDYA)-tag (Y-11, sc-805) and MYC(EQKLISEEDL)-tag (9E10, sc-40) were
purchased from Santa Cruz Biotechnology. Secondary antibodies were purchased from GE
Healthcare Life Sciences and consisted of α-mouse (NA931V) or α-rabbit (NA934V)
horseradish peroxidase-conjugated antibodies. The anti-FLAG antibody resin used for
CoIP was from Genscript.
Luciferase Assays
Cells were plated in 24-well plates at 50,000 cells/well. The following day, cells
were transfected with PEI at a ratio of 5 μg PEI for every 1 μg DNA. Cells were transfected
with 100 ng/well Hes5-luciferase and 10 ng/well of the various NICD constructs. To
normalize data for transfection efficiency and potential cell growth/death, we co-
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transfected with 10 ng/well of a CMV-β-Galactosidase construct. Cells were lysed 48 hours
post-transfection in 1x firefly luciferase lysis buffer (Biotium). Lysates were analyzed
following the manufacturer’s protocol (Firefly Luciferase Assay Kit, Biotium) using a
Promega© Glomax Multi Detection System luminometer. Luciferase activity was
normalized to β-Galactosidase activity (Promega) and values were reported as a fold
change to control. To minimize transfection variations and output noise, all conditions were
performed in triplicate for each independent experiment.
RT-PCR Analysis
A variety of cell lines were grown to collect their mRNA and analyze their Notch
expression profiles. Cells were plated in 10 cm dishes and grown until 80% confluence.
To collect the cells and their mRNAs, they were washed with 1xPBS and lysed with
RiboZol RNA Extraction Reagent (Amresco). mRNA was collected and purified following
the manufacturer’s recommended protocol. Equivalent amounts of RNA was reverse
transcribed with iScript (Bio-Rad) following the manufacturer’s protocol and diluted for
PCR analysis. Primers used to target human Notch mRNAs are listed in Supplementary
Table 2.1. Primers targeting 18S rRNA was used as an internal control to check cDNA
quality.
Chromatin IP
Chromatin immunoprecipitation (ChIP) analyses were performed as previously
described 207, with minor modifications including omission of SDS from the dilution, highsalt wash, and elution buffers, and omission of spermidine from the micrococcal nuclear
buffer. 293T cells were transfected with two differentially tagged NICDs and then 48 hours
later were fixed by formaldehyde-induced crosslinking and the nuclear fraction was
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isolated and collected. Micrococcal nuclease (NEB) was used to cut the chromatin into
300-1,500 base pair fragments, the nucleus briefly sonicated to lyse the fraction, and the
DNA collected. To specifically isolate the dimerized complexes bound to DNA, they were
placed through two rounds of selection, targeting both partners within the Notch dimer.
The first round of selection was performed with anti-FLAG G1 affinity resin (GenScript),
samples thoroughly washed, and complexes eluted with 3xFLAG-peptide (ApexBio).
Those complexes were placed through a second round of selection, probing for an HAtagged NICD partner, with biotinylated HA antibodies (Bioss). These targets were
precipitated out of solution with streptavidin magnetic beads (NEB), thoroughly washed
again, and the DNA was isolated out of the complexes with Proteinase K (Amresco) and
reverse crosslinking. DNA was cleaned and purified with a PCR purification kit and
samples were analyzed for Notch-dimer targets using Hes1 or Hes4 primers as indicated in
supplementary tables.
Results
NICD dimerization in mammalian cells
Previous work revealed the canonical crystal structure of the mammalian Notch
transcriptional complex containing fragments of RBPJ, MAML1, and the N1ICD ankyrin
domains in a head-to-head dimerized state 29,30. Nam et al., 29 further defined key residues
in the Notch1 NICD (N1ICD) ankyrin domain critical for dimerization of N1ICD
molecules and determined that these residues are highly conserved in Notch 2-4 (N2ICD,
N3ICD, N4ICD). This data suggested that all Notch NICD domains may engage in headto-head dimerization interactions. Furthermore, given the overall sequence similarity of
the Notch ankyrin domains and the conservation of these key amino acids required for
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dimerization, it was hypothesized that NICD domains may also be able to engage in
heterodimeric interactions, although this has not been investigated.
To test this hypothesis, we first established a cellular co-immunoprecipitation (COIP) assay to monitor NICD homodimerization. To differentiate between two dimerizing
versions of the same molecule, we generated various plasmids encoding FLAG-, MYC, or
HA-tagged versions of mouse NICD molecules. 293T cells were transiently co-transfected
with cDNAs encoding one FLAG-tagged and a second MYC- or HA-tagged pair of NICD
molecules. Anti-FLAG co-immunoprecipitation was used to isolate FLAG-tagged NICDs,
then immunoblotting with anti-MYC or anti-HA antibodies was used to detect MYC- or
HA-tagged Co-IP NICD partners, depending on combination.
To validate this co-immunoprecipitation system, we first sought to detect
homodimerization of N1ICD molecules, which had previously been observed to dimerize
by EMSA 30. We co-transfected 293T cells with a FLAG-tagged full-length N1ICD (1FL)
and a truncated MYC-tagged N1ICD (1T) similar to the N1ICD previously used in EMSA
experiments to study the interaction between N1ICD proteins (i.e. 347 amino acids of the
N1ICD C-terminus including the PEST domain deleted). As shown in figure 2.1A, MYCtagged truncated N1ICD readily precipitated with full-length N1ICD.

Importantly,

precipitation of MYC-tagged N1ICD was dependent on the presence of FLAG-tagged
N1ICD thus demonstrating specificity of the CO-IP approach.

Having successfully

observed N1ICD homodimerization, we next sought to monitor homodimerization of the
other NICD molecules (Fig 2.1B).

Interestingly, while we again observed

homodimerization between full-length and truncated N1ICD, homodimerization of two
full-length N1ICD molecules was only inconsistently observed. For example, results
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shown in figure 2.1B do not demonstrate homodimerization between full-length N1ICD
molecules while data shown in figure 2.2A does illustrate a successful coimmunoprecipitation of full-length N1ICD molecules.

This inconsistency of

homodimerization between full-length N1ICD molecules continued for unknown reasons
throughout the project. In contrast, experimentation with FLAG- and MYC-tagged fulllength N2ICD and N3ICD determined that the N2 and N3ICDs engaged in what appeared
to be fairly weak, but consistent, homodimerization (Fig. 2.1 deep exposure). Finally, and
in stark contrast, N4ICD homodimerization was consistently observed and appeared to be
significantly more robust compared to N1-3ICD homodimerization despite having
equivalent protein concentration in whole-cell lysates. Thus, these results demonstrated
that all NICD molecules are capable of homodimerization, although the strength of
homodimeric interactions did not appear to be equivalent for all dimer complexes.
Heterodimerization of NICD proteins
Due to the overall amino acid similarity of Notch proteins, especially in the ankyrin
domains, and the shared ability of the Notch proteins to form homodimers, we
hypothesized that NICD molecules may also be able to engage in heterodimeric complexes.
To address this possibility, we used the same co-transfection model as described above but
transfected cells with all permutations of epitope tagged N1, 2, 3, and 4ICD molecules. As
shown in figure 2.2a, full-length FLAG-N1ICD engaged in homodimeric interactions with
full-length HA-tagged N1ICD and heterodimeric interactions with the HA-tagged N2, N3,
and N4ICD molecules. Interestingly, N1ICD co-immunoprecipitated with N2, N3, and
N4ICD better than with N1ICD suggesting that N1ICD preferentially engaged in
heterodimeric interactions. Moreover, N1ICD most strongly precipitated with N4CID.
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N2ICD also formed homodimers and heterodimers with each of the other NICDs and again,
the N2ICD-N4ICD interaction appeared to be the most robust (Fig. 2.2B). N3ICD formed
heterodimers with each of the other NICDs (Fig 2.2C) although dimerization with N1ICD
and N2ICD appeared to be weak (Fig 2.2C dark) and as before, the interaction between
N3ICD and N4ICD appeared to be the strongest (Fig. 2.2C light). Finally, N4ICD
demonstrated strong heterodimerization with the other NICDs, but again, N4ICD
homodimerization appeared to be the most robust (Fig. 2.2D). Importantly, co-precipitation
of N4CID-HA was dependent on N4ICD-FLAG co-transfection thus again illustrating the
specificity of the co-immunoprecipitation system.
Collectively, this series of Co-IP experiments demonstrated that all Notch
heterodimer combinations appear to be capable of formation. Moreover, these results also
showed that Notch NICDs do not appear to equally engage in dimerization and that N4ICD
consistently displayed the most robust homodimerization and heterodimerization
compared to the other NICD molecules.
N4ICD homodimers and N4/N1 heterodimers outcompete N1ICD homodimers
Our results support the hypothesis that all NICD domains can engage in both homoand heterodimer interactions. In cells that express multiple Notch proteins, it is therefore
possible that NICD heterodimerization may present an opportunity for diversification of
Notch signaling outputs through alternative dimerization similar to what has been
described for other transcriptional systems 208. To assess the expression of multiple Notch
receptors in single cell lines, and thus the possibility of NICD heterodimerization, we
screened several cell lines for co-expression of Notch receptors. Reverse-Transcription
PCR (RT-PCR) was used to monitor mRNA expression of each Notch protein. As shown
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in figure 2.3A, each of the cell lines examined expressed at least two Notch receptors, while
several expressed three or even all four Notch receptors. Consistent with previous results
67

, Notch4 expression was limited to the endothelial cell lines (i.e. HUVEC and HMEC).
Based on our observation that the majority of cell lines express more than one

Notch protein and our results showing that N4ICD demonstrates the strongest potential for
dimerization in our system, we next sought to determine if N4ICD would dominate dimer
formation even when expressed in tandem with N1ICD. To accomplish this, we performed
an experiment wherein HA-tagged N1ICD and N4ICD were allowed to simultaneously
compete for binding and co-immunoprecipitation with a single FLAG-tagged “bait”
protein (Fig 2.3B). FLAG-N1ICD or FLAG-N4ICD were co-transfected individually with
both HA-tagged N1ICD and HA-tagged N4ICD, and immunoprecipitated with anti-FLAG
antibodies as before. Despite nearly equivalent expression of HA-tagged N1ICD and
N4ICD in whole cell lysate, we observed that N1ICD preferred forming heterodimers with
N4ICD rather than engage in homodimer interactions, although N1ICD-N1ICD
homodimers were also detected. In contrast, we found that N4ICD preferentially engaged
in homodimer formation and we were unable to detect N4ICD-N1ICD heterodimers when
N4ICD was used as bait, possibly as a result of the stronger interaction between N4ICD
molecules.
Ankyrin domains are not required for NICD dimerization
The Notch ankyrin domains have been shown to interact in a head-to-head
orientation that is important for NICD dimerization 29,30. Given our results, we sought to
determine if the NICD ankyrin domains were important for NICD dimerization in our
immunoprecipitation assay. Arg1984 within the human N1ICD ankyrin domain was
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previously identified as important for NICD dimerization and transcriptional responses
from promoters with paired RBPJ binding sites such as the Hes5 promoter

29,30

. Using

sequence alignments, we found equivalent arginine residues in the mouse Notch1 and
Notch4 NICDs (Arg1974 and Arg1685 respectively) and performed site-directed
mutagenesis to change these arginines to alanine residues. To confirm that these mutations
decreased transcriptional activity from paired RBPJ sites, we monitored luciferase
expression downstream from the Hes5 promoter that was previously used by Arnett et al.,
30

to monitor NICD transcriptional activity. This element contains paired RBPJ sites in a

“head-to-head” orientation that are important for efficient transcription from this promoter.
As shown in figure 2.4A, ankyrin mutant N1ICD demonstrated much weaker
transcriptional activity compared to wild-type N1ICD. Moreover, ankyrin mutant N4ICD
was also less efficient at driving Hes5 promoter activity, although the inherently low
transcriptional activity of wild-type N4ICD made this effect less obvious compared to
N1ICD.
Having confirmed the importance of the N1ICD and N4ICD ankyrin domains for
driving transcription from paired RBPJ binding sites, we next sought to determine if
ankyrin domains are required for NICD co-immunoprecipitation. To accomplish this, we
again used our co-immunoprecipitation assay to compare the ability of wild-type and
ankyrin mutant N1 and N4ICD to co-precipitate in 293T cells (Fig 2.4B). Due to the
inconsistencies observing full-length N1ICD homodimers previously stated, the Cterminally truncated N1ICD construct was again employed for this experiment. Despite the
importance of ankyrin domains for transcriptional activity, even when the ankyrin domains
of both NICD partners were mutated we were unable to detect significant changes in N1
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or N4ICD homodimerization. Interestingly, however, when we compared the ability of
HA-tagged N4ICD to CO-IP with various FLAG-tagged N1ICD truncations, we found that
N4ICD was able to CO-IP with a C-terminal deletion fragment of N1ICD (RAM/Ank) and
the isolated N1ICD ankyrin domain (Figure 2.4C). Finally, since the effect of the R1685A
mutation on N4ICD transcriptional activity was relatively weak, we further characterized
the role of the N4ICD ankyrin domain in N4ICD dimerization. We found that N4ICD
homodimerization was not affected by a complete deletion of the N4ICD ankyrin domain
(Figure 2.4D). Taken as a whole, these results confirm that NICD ankyrin domains are
important for NICD transcriptional activity and also suggest that NICD ankyrin domains
may contribute to NICD dimerization but are not required for NICD dimerization as
detected by CO-IP.
Dimerization is controlled by NICD C-terminal domain
Analysis of N1ICD by both crystallography and EMSA has shown that N1ICD
homodimerization and transcriptional activity of homodimers appears to be dependent on
interactions between opposing ankyrin domains. Our results confirm that ankyrin domains
are important for NICD transcriptional activity but also suggest that NICD ankyrin
domains are dispensable for co-immunoprecipitation of NICD dimers. Therefore, it was
important to determine which domains of NICD molecules are important not only for the
dimerization of NICDs but also for dictating the differential strengths of NICD homo- and
heterodimerization that we had observed. To accomplish this, we took advantage of the
differential dimerization of the N1ICD and N4ICD dimers. We constructed chimeric
proteins that swapped the N-termini, ankyrin domains, and C-termini between N1ICD and
N4ICD (Fig 2.5A) and compared the ability of these constructs to co-immunoprecipitate.
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We found that the N1ICD and N4ICD N-terminus and ankyrin domains could be
interchanged without any obvious effect on dimerization (Fig 2.5B and C) suggesting these
sequences are interchangeable during dimerization and not important for controlling
differential NICD dimerization. In contrast, swapping the N4ICD C-terminus onto N1ICD
significantly enhanced dimerization (Fig 2.5B) whereas swapping the N1ICD C-terminus
to N4ICD drastically reduced N4ICD dimerization (Fig 2.5C). These results taken together
with those presented in figure 2.4 indicate that co-immunoprecipitation is not dependent
on interactions between ankyrin domains and that control of differential dimerization
resides in the C-terminal sequences. However, based on this experiment we were unable
to determine if the enhanced dimerization of N1ICD with the N4ICD C-terminal domain
was due to either the simple deletion of the N1ICD C-terminus, the addition of the N4ICD
C-terminal domain, or a combination of these changes. Yet, we had previously shown that
truncated N1ICD co-immunoprecipitated better than full-length N1ICD suggesting the
N1ICD C-terminal domain contains a dimerization inhibition domain. Similarly, we were
also unable to conclude if decreased dimerization of N4ICD with N1ICD C-terminal
domain was due to the deletion of a dimerization enhancer in the N4ICD C-terminal
domain, addition of the N1ICD C-terminal domain, or a combination of these changes.
N4ICD contains a dimerization enhancing domain
Having shown that the N4ICD C-terminal domain was associated with enhanced
dimerization potential, our next goal was to dissect the N4ICD C-terminal domain to
identify regions important for strong dimerization. To accomplish this, we created a
progressive series of FLAG-tagged N4ICD C-terminal deletions (summarized in figure
2.6A) and compared dimerization between full-length and truncated N4ICD. To our
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surprise, we failed to observe any effect of N4ICD C-terminal deletion on dimerization
between mutant and full-length N4ICD (Fig 2.6B). According to Vasquez et al., 32 NICD
domains dimerize through interactions between the N- and C-termini of dimerizing
molecules. Based on this, we rationalized that a single full-length C-terminal domain may
still be sufficient to promote strong dimerization.

To confirm this, we compared

dimerization of two truncated N4ICDs or two WT N4ICDs in our co-immunoprecipitation
assay. As shown in figure 2.6C, CO-IP between truncated N4ICDs was significantly
weaker compared to WT N4ICDs suggesting that an enhancer of dimerization resides in
the N4ICD C-terminus. Therefore, we next compared dimerization between C-terminal
truncated HA-tagged N4ICD, and the set of FLAG-tagged C-terminal progressive
truncations. As shown in figure 2.6D, deletion of the most C-terminal 88 amino acids did
not impact dimerization. However, further deletion of the most C-terminal 113 amino acids
significantly decreased dimerization while deletion of the entire C-terminal 138 amino
acids prevented dimerization entirely.
To determine if the 50 amino acid region between amino acids A1826 and C1876
(i.e. the region of interest or ROI) was sufficient by itself to enhance NICD dimerization,
we swapped this ROI into the equivalent site of N1CID and again compared coimmunoprecipitation between various NICD molecules. As shown in figure 2.6E, despite
the introduction of the N4ICD ROI into N1ICD, we were still unable to consistently
observe dimerization between N1ICD molecules. However, dimerization was consistently
increased between N4ICD and the modified N1ICD containing the N4ICD ROI. Based on
this observation we believe the 50 amino acid region directly C-terminal to the N4ICD
ankyrin domain, between amino acids A1826 and C1876, is responsible for efficient
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N4ICD dimerization and that efficient dimerization between N4ICDs requires only a single
N4ICD C-terminus.
Dimerization of NICD domains does not correlate with transcriptional activity
Our results demonstrated that the N4ICD displays significantly stronger
dimerization potential compared to the other NICDs. Optimal activation of some Notch
promoters including the Hes5 promoter is dependent on NICD dimerization since the RBPJ
binding sites in these promoters are arranged in a head-to-head orientation or SPS site.
Given this, we hypothesized that increased dimerization would correlate with increased
transcriptional activity from the Hes5 promoter, which we previously confirmed, requires
NICD dimerization for optimal transcriptional activation (Fig 2.4). 293T cells were
transfected with luciferase reporters driven from the Hes5 promoter and various chimeric
proteins developed in figure 2.5. As shown in figure 2.7A, chimeric N1ICD/N4ICD
proteins did display somewhat altered transcriptional activity compared to N1ICD,
however, the addition of the N4ICD C-terminal decreased transcriptional activity despite
increasing the dimerization activity of N1ICD. Conversely, the addition of the N1ICD Cterminal to N4ICD did not significantly change N4ICD transcriptional activity despite
decreasing N4CID dimerization potential. Interestingly, swapping the N4ICD ankyrin
domain to N1ICD decreased reporter activity while swapping the N1ICD ankyrin domain
to N4ICD increased transcriptional activity despite these swaps having no discernable
effect on dimerization. Therefore, these results further suggested that dimerization of
NICD proteins (as measured by co-immunoprecipitation) does not directly correlate to
transcriptional activity.
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NICD molecules heterodimerize on DNA
Our results indicated that dimerization between NICD molecules (as measured by
Co-IP) did not directly correlate to transcriptional activity. Nonetheless, dimerization
between NICD molecules on Notch sensitive promoters has been observed by X-ray
crystallography and EMSA analysis. These two observations appeared to be in conflict
and therefore suggested that NICDs may exist in multiple dimerization states. One state
was detected by co-immunoprecipitation, dependent on NICD C-terminals, but did not
apparently correspond to transcriptional activity. The second state was transcriptionally
active and dependent on interactions between ankyrin domains but was apparently not
detected by Co-IP. These observations raised the important question whether or not the
NICD complexes that were being recovered by Co-IP were engaged in heterodimer
complexes on DNA or rather were strictly in a non-transcriptional state as suggested by
Vasquez et al., 32. To address this question, we transfected 293T cells with combinations
of FLAG-tagged N1ICD or N4ICD coupled with HA-tagged N1ICD or N4ICD binding
partners. DNA/protein complexes were crosslinked, fragmented by micrococcal nuclease
treatment, and lysates were subjected to a two-step co-immunoprecipitation, first with antiFLAG resin and second with anti-HA antibodies. Control samples included transfection
with FLAG-tagged N1ICD alone and a single anti-FLAG immunoprecipitation step
(+control) and negative control that was transfected with HA-tagged NICD and subjected
to the two-step Co-IP procedure. In all cases, precipitated DNA was detected by PCR with
oligos that were designed to flank the paired head-to-head binding sites within the Hes4
and Hes1 promoters. As shown in figure 2.8A, both Hes1 and Hes4 sequences were
detected in the precipitated chromatin of all NICD combinations. Importantly, the ChIP
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was specific since Hes4 and Hes1 promoters were not recovered if a FLAG-tagged protein
was not included. This result showed that NICD molecules were engaged in heterodimer
complexes on DNA. Based on this result, it was logical to compare the effect of N1ICD,
N4ICD, or N1ICD + N4ICD transfection on transcriptional activation from the Hes1 and
Hes4 promoters.

As shown in figure 2.8B, N1ICD activated the Hes1 promoter

significantly more than N4ICD, and the combination of N1ICD and N4ICD was heavily
biased towards lower activation. Interestingly, this trend was not consistent for the Hes4
promoter. Instead, Hes4 activation was equivalently activated by N1ICD, N4ICD, and the
N1ICD/N4ICD combination. Together these results indicated that not only were N1ICD
and N4ICD were forming homodimer complexes on DNA but also that N1ICD/N4ICD
heterodimers were forming on DNA. Moreover, these results also suggested that N4ICD
might be able to regulate N1ICD transcriptional activity on some promoters through
heterodimeric interactions.
Discussion
The Notch signaling mechanism is highly conserved in the earliest metazoans and
understanding Notch function is likely to be important not just for basic biology, but also
for the many diseases with which Notch malfunction has been associated. Previous work
found that Notch1 NICD domains dimerize through interaction between NICD ankyrin
domains and these findings are supported by both EMSA and X-ray crystallography.
However, it has also been shown that NICD dimerization is influenced by interactions
between the N- and C-terminals of dimerizing NICD molecules 32. The results presented
in this work expands these findings by showing that 1.) all mammalian Notch NICD
domains engage in homodimerization, 2.) that all mammalian Notch NICD domains also
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engage in heterodimerization, 3.) that the N4ICD demonstrates robust dimerization
potential compared to the other NICDs, and 4.) that the C-terminal domains of Notch1 and
Notch4 contain negative and positive regulators of dimerization respectively. Collectively,
our findings provide new insight into the molecular underpinnings of Notch signaling and
should help understand how Notch function, and malfunction, contributes to cell biology.
The majority of our understanding of Notch dimerization comes from
experimentation with partial domains of the three proteins found in the Notch tripartite
complex of (i.e. N1ICD, MAML, and RBPJ) that were produced in bacterial cells and
analyzed by EMSA, X-ray crystallography, or FRET 29,30,35,51. Overall, the major findings
of these studies were to determine the structure of the Notch tripartite complex and to
understand how NICD molecules engage in head-to-head dimerization through their
ankyrin domains. A limitation of these works, however, was that the partial N1ICD
molecules used primarily represented the highly conserved NICD ankyrin domains and
lacked the more divergent N- and C-termini. Therefore, it was concluded that N1ICD
dimerization is dependent on interactions between NICD ankyrin domains. This conclusion
was supported by reporter assays wherein mutation of key ankyrin domain residues
significantly reduced transcriptional activation from paired (head-to-head) RBPJ binding
sites

30

. Our results partially support this result since we also find that mutation of key

residues within the ankyrin domains decrease transcriptional activity from promoters
containing paired RBPJ binding sites. However, we also found that these same mutations,
which negatively impacted transcriptional activity, did not affect co-immunoprecipitation
of NICD molecules, although an isolated N1ICD ankyrin domain was capable, but not
required, for co-immunoprecipitation with N4ICD. Therefore, it appears that the previous
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conclusion that NICD dimerization is dependent on interactions between ankyrin domains
was oversimplified.
A major difference between our experiments and those that observed dimerization
through ankyrin domains

29,30,35,51

is that we employed NICD molecules with full-length

N- and C-terminal domains whereas the previous studies utilized ankyrin domains lacking
N- and C-terminal sequences. In addition, our experiments were performed with wholecell lysates whereas much of the work cited above has been performed with purified
components. Using these full-length NICD constructs, we found that N-terminal sequences
in N1ICD and N4ICD appeared to perform equivalent and interchangeable roles in
dimerization. In comparison, the N4ICD C-terminal sequence enhanced dimerization
whereas the N1ICD C-terminal decreased dimerization.

These findings are largely

compatible with results presented earlier by Vasquez et al.,

32

who also used co-

immunoprecipitation to demonstrate that dimerization of N1ICD also engages interactions
between the N- and C-terminal domains of N1ICD.
As outlined above, there are conflicting observations regarding the nature of NICD
dimerization. We envision two possibilities that may help to unify the existing data. The
first possibility is a “two-state model” where NICD molecules can exist in two different
states, each with different functions. In the first state, (which may not require DNA)
dimerization is driven primarily by interactions between the N- and C-termini of
dimerizing NICDs. This first state may exist independently of transcription or even DNA
binding and the ankyrin domains would have a negligible effect on dimerization. This is
supported by our co-immunoprecipitation experiments showing that N4ICD lacking its
ankyrin domain is still capable of dimerization (figure 2.4D). This model is favored (and
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initially proposed) by Vasquez et al., 32 who hypothesize that NICD multimers (first state)
are required to recruit MAML during assembly of the final NICD transcriptionally active
tripartite complex, (i.e. the second state). In this second state, NICD molecules together
with and MAML dimerize on head-to-head SPS sites in an ankyrin domain-dependent
fashion. The role of the N- and C-termini in this second state appears to be secondary to
the ankyrin domains although evidence suggests the N- and C-terminals still have a role
during transcriptional activity. For example, we found that swapping the N4ICD Cterminal onto N1ICD decreased transcriptional activity from the Hes5 promoter (figure
2.7). Similarly, Blain et al., 209 observed that overexpression of N1ICD with a C-terminal
238 amino acid deletion does not recapitulate normal Notch signaling. This is a point of
practical concern since this Notch1 C-terminal truncation construct has been described as
“full-length” and used in a number of studies, including the generation of a transgenic
mouse model for Notch activation

210

. In addition to this “two-state” model of NICD

dimerization, a second possible model of NICD dimerization is that a single dimer state
exists that simultaneously engages the N-terminals, ankyrin domains, and C-terminals of
dimerizing NICDs.

In this model, the ankyrin domains might contribute less to

dimerization but more to transcriptional activity while the N- and C-terminals might still
be primarily responsible for dimerization perhaps through reciprocal interactions around
the central ankyrin domain interactions. However, since the existing NICD structural
models use isolated ankyrin domains, this remains a hypothesis and would need to be tested
in future experiments.
One of the important results from our work is the confirmation that all NICD
domains are capable of homodimerization as previously demonstrated

29

. An important
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difference between previous homodimerization studies however is that we monitored
homodimerization of full-length NICD molecules in whole-cell lysates compared to
purified ankyrin domains in in-vitro EMSA assays. Therefore, our results add an important
perspective to the understanding of NICD homodimerization. Taking this a step further,
our co-immunoprecipitation studies also discovered that all NICD domains engage in
heterodimeric interactions. Moreover, the apparent strength of interaction between NICDs
was not equivalent. Instead, we found that N4ICD appeared to most robustly form NICD
heterodimers but had an even greater preference for N4ICD homodimerization. The
implications of this finding remain unknown; however, several tantalizing possibilities
present themselves. First, we and others have shown that many cells express more than
one Notch receptor (figure 2.3A). Since the various NICD molecules demonstrate varying
transcriptional activity, it is possible that NICDs with lower transcriptional activity such as
N3ICD or N4ICD may act as negative regulators for N1ICD or N2ICD by engaging in
heterodimeric interactions at sequence paired sites. In particular, since N4ICD seems to
promiscuously engage in dimerization and is expressed almost exclusively in endothelial
tissues, it is tempting to speculate that N4ICD may serve to regulate Notch1 function in the
vascular system. In support of this, we confirmed the presence of N1/N4ICD heterodimers
on the Hes1 and Hes4 promoters by ChIP analysis and found that N1ICD transcriptional
activity on the Hes1 and Hes4 luciferase reporters was reduced by co-transfection with
N4ICD (Figure 2.8). Care must be taken to interpret this result however since the overall
reporter activity probably represents a sum of N1ICD homodimers, N4ICD homodimers,
and N1/N4ICD heterodimers.
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In conclusion, our results suggest that there remain many important questions about
the basic mechanism of Notch signaling. Major outstanding questions that remain include
the formation and function of the NICD dimerization complex(s), the extent to which
NICD

heterodimerization

influences

Notch

signaling

output,

and

if

Notch

homodimerization or heterodimerization can be regulated by cell signaling. Answering
these questions should shed light on Notch signaling and help to understand how this
ubiquitous signaling mechanism regulates cell biology.
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Figure 2.1:

Detection of Notch intracellular domain homodimer complexes within
a cell culture model

(A) HEK293T cells were co-transfected with cDNAs encoding FLAG-tagged full-length
N1ICD and MYC-tagged truncated N1ICD (1T). Whole-cell lysates were
immunoprecipitated with anti-FLAG antibodies and western blotted with anti-MYC and
anti-FLAG antibodies. Input represents 10% of whole-cell lysate used in
immunoprecipitation. Shown is a representative image of a single experiment that was
performed four independent times. (B) FLAG- and MYC-tagged N1-4ICDs were
transfected into 293T cells, homodimer complexes were detected by immunoprecipitation
(IP) with an anti-FLAG antibody and western blotting with anti-MYC antibodies. A
longer anti-MYC western blot exposure (deep exposure) was required to visualize N2 and
N3ICD homodimers. Shown is a representative image of a single experiment that was
performed four independent times.
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Figure 2.2:

Detection of Notch intracellular domain homo- and heterodimer
complexes

293T cells were transfected with FLAG- and HA- tagged species of various NICDs and
dimerization was detected by co-immunoprecipitation with anti-FLAG antibodies and
western blotting with anti-HA antibodies. In all panels, Input represents 10% of wholecell lysates before CO-IP. The heterodimerization possibilities are represented with (A)
N1ICD, (B) N2ICD, (C) N3ICD, and (D) N4ICD. To prevent confounding results from
residual unstripped antibodies, lysates were run twice on two different membranes for
cleaner western blot analysis. Panel D also includes a negative FLAG-tagged NICD lane
(-), controlling for non-specific interactions between HA-tagged protein on anti-FLAG
antibody resins.
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Figure 2.3:

N4ICD outcompetes N1ICD

(A) RT-PCR was used to monitor expression of Notch proteins in cell lines from various
tissues. +/- denotes +RT experimental samples and -RT control samples. Image shown
represents data from two independent repetitions. (B) HA-tagged N1ICD and N4ICD
were simultaneously co-transfected with either FLAG-tagged N1ICD or N4ICD.
Dimerization was detected by precipitation with anti-FLAG antibodies and western
blotting with anti-HA antibodies. Input represents 10% of whole cell lysate used in the
immunoprecipitation. The image depicts a representative example of a single experiment
that was performed three times.
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Figure 2.4:

Ankyrin domains are not required for NICD dimerization

293T cells were co-transfected with Hes5-promoter luciferase reporter and wild-type
(WT) or corresponding ankyrin domain mutant (Mut) NICDs. Reporter activation is
compared to its basal activity in cells, which received an equivalent amount of empty
overexpression vector (EV). Shown are the average +/- SE of six experiments.
Transfection efficiency was normalized by co-transfection with CMV-β-gal reporter
plasmids and measuring β-gal activity. Statistical significance was determined through a
student’s two-tailed t test, where *** is p < 0.001, and * is p < 0.05. (B) 293T cells were
transfected with pairs of cDNAs encoding FLAG- and MYC-tagged WT NICD domains
or mutant FLAG- and MYC-tagged mutant ankyrin NICD domains. Anti-FLAG
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antibodies were used to isolate FLAG-tagged proteins and western blotting with antiMYC antibodies was used to detect interacting NICD domains. Shown is a
representative image of a single experiment that was performed four independent times.
To account for dimerization intensities, the figure includes a light and dark exposure of
the co-immunoprecipitated MYC-partners. (C) 293T cells were transfected with HAtagged N4ICD and various FLAG-tagged N1ICD constructs including the full-length
(FL) N1ICD, N1ICD lacking the C-terminus (RAM/Ank), and the isolated N1ICD
ankyrin domain (Ank). Anti-FLAG antibodies were used to detect interacting HA-tagged
molecules. Shown is a representative image of a single experiment that was performed
three times. (D) 293T cells were transfected with full-length HA-tagged N4ICD and
either full-length or ankyrin deletion mutant (ΔAnk) FLAG-tagged N4ICD. CO-IP and
western analysis was performed as above. In all panels, Input represents 10% of whole
cell lysate from each sample as a control for protein expression.
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Figure 2.5:

NICD C-termini regulate dimerization

(A) Chimeric proteins were made by swapping the N-terminals (N), Ankyrin domains
(A), and C-terminals (C) between wild-type N1ICD and N4ICD. Amino acids demarking
domain positions on N1ICD and N4ICD are indicated. (B) CO-IP between WT HAtagged N4ICD and chimeric FLAG-tagged N1ICD. (C) CO-IP between WT HA-tagged
N4ICD and chimeric FLAG-tagged N4ICD. In B and C, Input represents 10% of whole
cell lysate as a loading control. Shown are representative images of an experiment that
was performed three independent times.
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Figure 2.6:

Identification of dimerization enhancer domain in Notch4

(A) N4ICD was progressively truncated beginning from the C-terminal. Shaded, is the
region of interest (ROI) of N4ICD linked to enhanced dimerization potential. (B) Various
FLAG-tagged N4ICD truncations were co-transfected with full-length HA-tagged N4ICD
and co-immunoprecipitated. (C) Deletion of the N4ICD C-terminal prevents efficient
dimerization. The C-terminal 138 amino acids were deleted from FLAG- and HA-tagged
N4ICD then full-length (4) or truncated (4T) cDNAs were transfected into 293T for
immunoprecipitation analysis. (D) Paired sets of progressive N4ICD C-terminal
deletions were monitored for dimerization by immunoprecipitation. (E) Amino acids
A1826 to C1876 corresponding to the N4ICD ROI, were swapped into the corresponding
region downstream of the N1ICD ankyrin domain then co-transfected with various
combinations of N1ICD or N4ICD. Co-immunoprecipitation was used to monitor
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interactions. All panels depict representative images of experiments that were performed
at least three independent times.
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Figure 2.7:

Transcriptional activity of N1ICD / N4ICD chimeric proteins

(A and B) 293T cells were transfected with the Hes5-luciferase reporter construct and
various chimeric proteins. Shown is the average +/- SE of six independent experiments.
*** indicates p<.01, student’s t-test.
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Figure 2.8:

Detection of NICD homodimer and heterodimer complex on DNA

(A) 293T cells were transfected with combinations of FLAG-tagged N1ICD or N4ICD
and FLAG- or HA-tagged binding NICD partners. ChIP was performed by two-step COIP with anti-FLAG then anti-HA antibodies. A positive control reaction was transfected
with FLAG-tagged N1ICD alone and subjected to anti-FLAG CO-IP. A negative control
reaction was transfected with HA-tagged N1ICD and subjected to anti-FLAG and antiHA CO-IP. Hes1 and Hes4 promoter sequences were detected by PCR with antibodies
flanking the head-to-head binding sites in each promoter. Shown is a representative
image of a single experiment that was performed three independent times with similar
results. (B) 293T cells were transfected with Hes1 (top) or Hes4 (bottom) promoter
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luciferase reporters and equivalent amounts of either empty CMV control vector, N1ICD,
N4ICD, N1 and N4ICD. Shown are the average +/- SE of six independent experiments.
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Figure S2.1: Diagram of important landmarks in N1ICD and N4ICD

Indicated in each figure are the 1.) sites of antiparallel multimerization as defined by
Vasquez et al., 32 2.) ankyrin dimerization interface with key amino acids indicated based
on sequence alignment between human and mouse NICDs as described by Nam et al., 29.
3.) The region of N4ICD C-terminal we define as important for enhanced dimerization,
4.) the transactivation domain (TAD) present in N1ICD but not N4ICD, and 5.) the PEST
domain present in both N1ICD and N4ICD.

Transfer N1ICD into pcDNA3.1-MycHis B

Transfer N2ICD into pcDNA3.1-MycHis B

Transfer N3ICD into pcDNA3.1-MycHis B

Transfer N4ICD into pcDNA3.1-MycHis B

Transfer N1ICD into pKH3

Transfer N2ICD into pKH3

Transfer N3ICD into pKH3

Transfer N4ICD into pKH3

Clone Hes4 promoter to pGL3-Basic

285
N1ICD-MYC

286
N2ICD-MYC

287
N3ICD-MYC

288
N4ICD-MYC

296
N1ICD-HA

297
N2ICD-HA

298
N3ICD-HA

299
N4ICD-HA

391
Hes4-Luciferase

GGCGGCTCTAGAGTTCAGATTTCTTACAACCGAGTTTAAGGG
GGCCGGGGTACCCGAGGCGTGACTGACA
GGCCGGGAGCTCCAGGCCGTTTCCCTATTTAAG

FWD (KPN1)
REV (SAC1)

GGCGGCGTCGACACCATGGTCCTCCAGCTCATTCGG
FWD (SAL1)
REV (XBA1)

GGCGGCTCTAGAGGCCATCACCTGCCTCTTG

GGCGGCGTCGACACCATGATGGTTGCCAGGCGAAGC

FWD (SAL1)
REV (XBA1)

GGCGGCTCTAGATGCATACACCTGCATGTTGCTGTG

GGCGGCGTCGACACCATGATGGCCAAGCGGAAGCG

FWD (SAL1)
REV (XBA1)

TTATTATCTAGATTTAAATGCCTCTGGAATGTGG

TTATTAGTCGACACCATGGTGCTGCTGTCCCGC

FWD (SAL1)
REV (XBA1)

GGCGGCTCTAGAGCGTTCAGATTTCTTACAACCGAGTTTAAGGG

GGCGGCGGTACCACCATGGTCCTCCAGCTCATTCGG

FWD (KPN1)
REV (XBA1)

GGCGGCTCTAGAGGCCATCACCTGCCTCTTG

GGCGGCGGTACCACCATGATGGTTGCCAGGCGAAGC

FWD (KPN1)
REV (XBA1)

GGCGGCTCTAGATGCATACACCTGCATGTTGCTGTG

GGCGGCGGTACCACCATGATGGCCAAGCGGAAGCG

FWD (KPN1)
REV (XBA1)

TTATTATCTAGAGCTTTAAATGCCTCTGGAATGTGG

TTATTAGGTACCACCATGGTGCTGCTGTCCCGC

REV (XBA1)

FWD (KPN1)

Sequence (5'→3')

Primers Utilized Throughout the Manuscript

The following constructs were cloned with a restriction enzyme mediated approach:
Plasmid
Desired Construct/ Primer Function
Dir.
Number

Supplementary Table 2.1
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284
N4ICD-Flag (R1685A)
290
N4ICD-Myc (R1896A)
361
N4ICD-HA (R1896A)
Mutagenesis of N4ICD
ankyrin R1685A
REV

FWD

GTCTGGGCGCTGGCCAATAGGAGCT

CCAGCGCCCAGACTACGGTGGACG

The following constructs were cloned with the desired mutation inserted within partially overlapping primers:
Plasmid #
Desired Construct/
Dir.
Sequence (5'→3')
Plasmid name
Primer Function
281
N1ICD-FLAG (R1974A)
CCGGAACGCCGCCACAGATCTGGATGCCCGAATGC
FWD
355
N1ICD-MYC (R1974A)
Mutagenesis of N1ICD
ankyrin domain (R1974A)
289
N1ICD-MYC (R1974A) (ΔS2184)
GTGGCGGCGTTCCGGAGCAGGATCTGGAAGACACC
REV
358
N1ICD-HA (R1974A)
282
N2ICD-FLAG (R1934A)
CCGCAACGCCGTAACCGATCTGGATGCCAGAATGA
FWD
356
Mutagenesis of N2ICD
N2ICD-MYC (R1934A)
ankyrin R1934A
359
GTTACGGCGTTGCGGATCAGAATCTGAAAGACACCTTGGGC
REV
N2ICD-HA (R1934A)
283
N3ICD-FLAG (R1896A)
CAGGAACGCCTCCACTGACCTGGATGCCCGAATGG
FWD
357
Mutagenesis of N3ICD
N3ICD-Myc (R1896A)
ankyrin R1896A
360
GTGGAGGCGTTCCTGATGAGAATCTGGAAGACACCCTGGG
REV
N3ICD-HA (R1896A)

90

N1ICD ankyrin
Alone Creation (HA
Vector)

N1ICD/N4N-Term
Chimera Creation

N1ICD/N4Ank
Chimera Creation

N1ICD/N4C-Term
Chimera Creation

362
N1ICD/N4 Nterminal-FLAG

363
N1ICD/N4-AnkFLAG

364
N1ICD/N4 Cterminal-FLAG

N1ICD ankyrin
Alone Creation
(Myc Vector)

N1ICD ankyrin
Alone Creation
(Flag Vector)

383
N1ICD-ANK-HA

386
N1ICD-ANK-MYC
(R1974A)

384
N1ICD-ANK-MYC

385
N1ICD-ANK-FLAG
(R1974A)

382
N1ICD-ANK-FLAG

N4 C-Terminus
Isolation

N1ICD
Linearization

N4 ankyrin
Isolation

N1ICD
Linearization

N4 N-Terminus
Isolation

N1ICD
Linearization

N1 ankyrin
Isolation

HA Vector
Linearization

N1 ankyrin
Isolation

Myc Vector
Linearization

N1 ankyrin
Isolation

Flag Vector
Linearization

GCTCTAGAGGGCCCGCGG

FWD

AGTACAACCTGGTGCGCAGCCACGCACGCACCACGCCG
AGGGATGCCACCCGGGATCCCTAGTTCAGATTTCTTACAACCGAGTTTAAGGGAATCTC

REV

GGATCCCGGGTGGCATCC

FWD

FWD

GCAGTGCCATGCAGCTGTGGCGCACGGGCCTCCTGCGT

REV

GCTGCGCACCAGGTTGTAC

TGGATGCTGACTGCATGGATGTGGACACCTGTGGACCTGATGGG

REV

ATCCATGCAGTCAGCATCCACCTCC

CCACAGCTGCATGGCACTGCC

FWD
REV

TCTGGTCCTCGAACATTGACATCCAGAACCTCCGATTC

REV

FWD

GCCTGCAGGTCGACTCTAGAGTCCTCCAGCTCATTCGG

FWD

GTCAATGTTCGAGGACCAGATG

FWD
TCTAGAGTCGACCTGCAGGC

TCGTATGGGTACATTCTAGAGCTGCGCACCAGGTTGTAC

REV

REV

TTCTGCAGGTCGACACCATGGTCAATGTTCGAGGACCAGATG

FWD

TCTAGAATGTACCCATACGATGTTC

FWD
CATGGTGTCGACCTGCAG

AACCGCGGGCCCTCTAGAGCGCTGCGCACCAGGTTGTA

REV

REV

TAGTTAAGCTTGGTACCATGGTCAATGTTCGAGGACCAGATG

FWD

CATGGTACCAAGCTTAACTAGCCAGC

GATGCCACCCGGGATCCTTAGCTGCGCACCAGGTTGTAC

REV

GCCTGCAGGTCGACTCTAGAGTCAATGTTCGAGGACCAGATG

REV

TCTAGAGTCGACCTGCAGG

TAAGGATCCCGGGTGGCATC

Sequence (5'→3')

FWD

REV

FWD

The following constructs were cloned with Gibson Assembly:
Plasmid #
Gibson
Construct
Dir.
Plasmid name
Component
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N4ICD/N1Ank
Chimera Creation

N4ICD/N1C-Term
Chimera Creation

366
N4ICD/N1-AnkFLAG

367
N4ICD/N1 Cterminal-FLAG

388
N1ICD/N4 ROI-HA

N1ICD/N4ROI
Chimera Creation

N4ICD/N1N-Term
Chimera Creation

365
N4ICD/N1 Nterminal-FLAG

387
N1ICD/N4 ROIFLAG

Construct

Plasmid #
Plasmid name

N4 ROI Isolation

Notch1
Linearization

N1 C-Terminus
Isolation

N4ICD
Linearization

N1 ankyrin
Isolation

N4ICD
Linearization

N1 N-Terminus
Isolation

N4ICD
Linearization

Gibson
Component

AGTACAACCTGGTGCGCAGCCACGCACGCACCACGCCG

FWD

GCCTTGAGGTCCTTAGCTTCGCAGCGAGCATACACCTTCCCTC

GCTGCGCACCAGGTTGTAC

REV

REV

GAAGCTAAGGACCTCAAGGC

CTCTAGACGGCTTCCGGTGCTTATTTAAATGCCTCTGGAATGTGGGTG

REV
FWD

CTACGCAGGAGGCCCGTGCGCCACAGCTGCATGGCACTG

FWD

GCACCGGAAGCCGTCTAGAGGATCCC

FWD
CGCACGGGCCTCCTGCGT

CCCGGCGTGGTGCGTGCGTGGCTGCGCACCAGGTTGTAC

REV

REV

GTGAATCGGAGGTTCTGGATGTCAATGTTCGAGGACCAGATG

CACGCACGCACCACGCCG

FWD

FWD

TCAGGTCCACAGGTGTCCACATCCATGCAGTCAGCATCCAC

REV

ATCCAGAACCTCCGATTCAC

AGGATGACGATGACAAGCTTGTGCTGCTGTCCCGCAAG

FWD

REV

AAGCTTGTCATCGTCATCCTTG

GTGGACACCTGTGGACCTG

Sequence (5'→3')

REV

FWD

Dir.
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381
N1ICD-RAM/ANK-MYC (ΔCTD)

374
N4ICD V1463-A1826 (-138) – HA

N4ICD C-Terminus
Truncations
(HA Vector)

N4ICD C-Terminus
Truncations

Creation of N1RAM/Ank
(ΔC-Terminus Domain)
(Myc Vector)

368
N4ICD V1463-H1951 (-13) -FLAG
369
N4ICD V1463-A1926 (-38) -FLAG
370
N4ICD V1463-R1901 (-63) -FLAG
371
N4ICD V1463-C1876 (-88) -FLAG
372
N4ICD V1463-C1851 (-113) - FLAG
373
N4ICD V1463-A1826 (-138) -FLAG

Creation of N1RAM/Ank
(ΔC-Terminus Domain)
(Flag Vector)

380
N1ICD-RAM/ANK-FLAG (ΔCTD)

The following constructs were cloned through blunt-end ligations:
Plasmid #
Desired Construct/ Primer
Plasmid name
Function
375
N1ICD-RAM/CTD-FLAG
376
Creation of N1RAM/CTD
N1ICD-RAM/CTD-HA
(Δankyrin Domain)
377
N1ICD-RAM/CTD-MYC
378
N4ICD-RAM/CTD-FLAG
Creation of N4RAM/CTD
(Δankyrin Domain)
379
N4ICD-RAM/CTD-HA

TCGTATGGGTACATTCTAGACGCACGGGCCTCCTG

GGCTTCCGGTGCCTACGCACGGGCCTCCTG
REV

REV

GGCTTCCGGTGCCTACCCGCGCGGGCG

REV

TCTAGAATGTACCCATACGATGTTCCAG

GGCTTCCGGTGCCTAGCAGCGAGCATACACCTTCC

REV

FWD

GGCTTCCGGTGCCTAGCGTCGTCCACGGGAG

REV

GGCTTCCGGTGCCTACGCACTGCAGGCGGAG

REV

TAGGCACCGGAAGCCGTCTAGAGGATCC

FWD

GGCTTCCGGTGCCTAGTGAACTGGAAGACCCCAGG

GCTGCGCACCAGGTTGTAC

REV

REV

GCTCTAGAGGGCCCGCGG

FWD

GCTGCGCACCAGGTTGTAC

ATCCAGAACCTCCGATTCAC

REV

REV

CACGCACGCACCACGCCG

FWD

TAAGGATCCCGGGTGGCATC

ATCCATGCAGTCAGCATCCACCTCC

REV

FWD

CCACAGCTGCATGGCACTGCC

Sequence (5'→3')

FWD

Dir.
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18S

Notch4

Notch3

Notch2

Notch1

Primers used for RT-PCR Analysis of the Notch Expression Profiles:

Human Hes4 Promoter Primer for Notch-Dimer Driven ChIP

Human Hes1 Promoter Primer for Notch-Dimer Driven ChIP

Primers used for Chromatin Immunoprecipitation Analysis:

TAGTAGCGACGGGCGGTGTG

CAGCCACCCGAGATTGAGCA
FWD
REV

AGAGGCACTCATTGTGATCAGCCT

ACTCCTGTGCCACTTGGAAGACAT

FWD
REV

AGCGGTTTCGGATGAGAATCTGGA

GATGGCATGGATGTCAATGTGCGT

FWD
REV

ACATAGGCACTGGGACTCTGCTTT

AATGGTGGCACATGTGTTGATGGG

FWD
REV

TCAATACACGTGCCCTGGTTCAGA

AGGTCAATGAGTGCAACAGCAACC

REV

FWD

CAGGCCGTTTCCCTATTTAAG

CGAGGCGTGACTGACA

FWD
REV

GGCCTCTATATATATCTGGGACTG

TCCTCCCATTGGCTGAAA

REV

FWD
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Abstract
Notch signaling is essential for multicellular life, regulating core functions such as
cellular identity, differentiation, and fate. These processes require highly sensitive systems
to avoid going awry, and one such regulatory mechanism is through Notch intracellular
domain dimerization. Select Notch target genes contain sequence-paired sites (SPS);
motifs in which two Notch transcriptional activation complexes can bind and interact
through Notch’s ankyrin domain, resulting in enhanced transcriptional activation. This
mechanism has been mostly studied through Notch1, and to date, the abilities of the other
Notch family members have been left unexplored. Through the utilization of minimalized,
SPS-driven luciferase assays, we were able to test the functional capacity of Notch dimers.
Here we show that the Notch 2 and 3 NICDs also exhibit dimerization-induced signaling,
following the same stringent requirements as seen with Notch1. Furthermore, our data
suggested that Notch4 may also exhibit dimerization-induced signaling, although the
amino acids required for Notch4 NICD dimerization appear to be different than those
required for Notch 1, 2, and 3 NICD dimerization.

Interestingly, we identified a

mechanical difference between canonical and cryptic SPSs, leading to differences in their
dimerization-induced regulation. Finally, we profiled the Notch family members’ SPS gap
distance preferences and found that they all prefer a 16-nucleotide gap, with little room for
variation. In summary, this work highlights the potent and highly specific nature of Notch
dimerization and refines the scope of this regulatory function.
Introduction
Notch signaling is a cornerstone of multicellularity and dictates cellular fate and
identity. Notch signaling is heavily influenced by microenvironmental cues 3, including
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adjacent “sending cells” which present any of five Notch ligands to up to four Notch
receptors expressed on so called “receiving cells”. Ligand bound and activated Notch
receptors undergo a series of proteolytic cleavages which release an active intracellular
domain (NICD) 22,23,211. This transcriptionally active fragment translocates to the nucleus
to act as a co-transcription factor. Common Notch signaling targets are transcription factors
themselves, which have their own broader implications and cascades, culminating in a
system which requires a fine-tuned, highly sensitive signaling network. Disruption of
Notch signaling, both through over- and under-activation, leads to a variety of
developmental abnormalities and cancers 4. Understanding mechanisms behind this precise
level of internal control may pave the way for treatments of many of its resulting disorders.
The mammalian Notch signaling system consists of four mostly homologous
receptors (Notch1-4) which are all activated through this manner. Each NICD molecule
can be readily split into three sections; the N-terminus which contains the RBPJ associated
module (RAM) domain, the central ankyrin domain, and a variable C-terminus which
houses the Pro-Glu-Ser-Thr (PEST) domain used in protein turnover and in some Notch
proteins, a transactivation domain (TAD). Through the RAM domain, all Notch proteins
bind to the same transcription factor, recombination signal binding protein for
immunoglobulin kappa J region (RBPJ, also commonly called CSL, CBF-1/Suppressor of
Hairless/Lag-1) 212. Upon NICD binding to RBPJ, a new NICD/RBPJ interface is formed
which recruits another co-activator, a member of the Mastermind-like (MAML) family 25.
This new tri-protein complex recruits a cascade of other transcriptional machinery to drive
transcription of its target genes 121. While each Notch protein contains the conserved RAM
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and ankyrin domains, their transcriptional activation profiles are not identical and are
largely dependent on context within promoter elements 28.
The DNA target sites which the Notch transcriptional activation complex (NTC)
binds to have been the subject of thorough analysis. The consensus binding site was
originally defined as a “TP1 element” with the sequence 5’ CGTGGGAAAAT 3’ that
recruits RBPJ to Notch responsive promoters 213,214. TP1 elements are found in a variety of
configurations within promoters. Perhaps most importantly, TP1 elements orientated in a
head-to-head directionality and separated by 16 base pairs (bp), also known as sequencepaired sites (SPS), enable cooperative binding of two NICD molecules

19,24

. This

cooperation results in better repression in the absence of NICD, and enhanced activation
in its presence 27,28. Upon modeling of two N1ICD transcriptional cores on a SPS, it was
proposed that complex dimerization occurs through the N1ICD ankyrin domain 29 and this
was further supported through crystallization of the interface 30. Importantly, theses SPSdriven promoters appear to be dimer-dependent. When dimerization was interrupted,
N1ICD’s transcriptional potential was substantially reduced on promoters containing SPSs
29,30

and could no longer induce T-cell acute lymphoblastic leukemia

31

. Together,

sequence-paired sites and Notch dimerization appear to be potent regulators of Notch
signaling and warrant a closer investigation into their mechanics.
In the search for new Notch responsive genes, ChIP-Seq approaches have recently
been adopted to identify new SPS sites based on DNA interaction with RBPJ. While the
NTC-dimer crystal structure dictates a 16-nucleotide spacer region, ChIP-Seq analysis by
Castel, et al. identified a variety of potential SPS-driven genes with spacer regions from 11
to 21 base pairs 33. These possible targets are opposed by in vitro analysis which observed
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a more limited spacer region of 15 to 17 base pairs 29,35. This discrepancy in spacer length
is further complicated due to ChIP-Seq approaches that experimentally identified
individual RBPJ binding sites then computationally screened for nearby secondary sites
33,35,175

. Screening for secondary sites however is not straightforward since loading of a

NTC onto a high-affinity site directly enables cooperativity on cryptic, low affinity sites
which may not even resemble traditional RBPJ binding sequences

30,31,35

. While the

transcriptional outcomes seem to be clear, the mechanisms dictating this SPS-response
within promoters and enhancers are not clearly understood.
While dimerization-induced signaling of Notch1 has been previously explored, the
ability, specifications, and limitations for the other members of the Notch family remain
unknown. To compare dimer-dependent signaling of the various NICDs, we generated
luciferase reporter constructs driven by either isolated sequence-paired sites from known
dimer-dependent promoters or an artificial/optimized SPS site. We observed that all NICDs
activate these promoters with varying efficiency. We also observed that Notch1, 2, and 3
functions through dimerization dependent mechanisms, while Notch4 appeared dimer
independent. Finally, we compared the optimal gap length within SPS sites and found that
all NICD molecules prefer promoters with 16bp between RBPJ binding sites, with little
room for deviation. These results should help us to understand how the various NICD
molecules interact in cells and potentially diversify Notch signaling outputs in cells that
express multiple Notch proteins.
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Materials and Methods
Cell Culture
HEK293T cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
(Mediatech, Inc.) supplemented with 10% EquaFetal Bovine Serum (FBS) (Atlas
Biologicals) and 1x penicillin-streptomycin solution (Mediatech, Inc.). Cells were grown
in 10 cm culture plates and subcultured at 70-80% confluency.
Expression and Reporter Plasmids
Protein expression constructs were obtained through the following: FLAG-N1ICD
(AddGene #20183), N2ICD (#20184), N3ICD (#20185), and N4ICD (#20186) were all
gifted by Raphael Kopan 28 and acquired through AddGene.org. All constructs code for the
intracellular domain of the mouse Notch proteins and have a 3xFLAG peptide tag on the
N-terminus. The N1ICD-MYC ΔS2184 construct, also a gift from Raphael Kopan

23

(#41730), includes a substantial C-terminal truncation, encoding mouse N1ICD V1744 to
S2184 with a MYC tag located at the C-terminus. The NICD coding regions were
subcloned into pKH3 (#12555), a gift from Ian Macara 206 to add a C-terminal 3xHA tag.
N1ICD (R1974A), N2ICD (R1934A), N3ICD (R1896A), and N4ICD (R1685A) mutants
were all created through site-directed mutagenesis of the NICDs based on sequence
alignment to identify amino acids (Figure S3.2) in mouse NICDs homologous to the human
N1CID R1984 site previously shown to be essential for NICD dimerization 30. The empty
coding vector pcDNA3.1/MYC-His was obtained from Invitrogen and pCMV-βGalactosidase was obtained from Clontech/Takara Bio.
Transcriptional reporter constructs were obtained or created as the following: Fulllength mouse promoters for Hes1 (#41723) and Hes5 (#41724) were a gift from Ryoichiro
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Kageyama and Raphael Kopan 215. 4xTP1 (#41726), a synthetic promoter containing four
high-affinity RBPJ binding sites in tandem, was a gift from Raphael Kopan

216

. These

promoter sequences were designed and cloned into pGL2-Basic (Promega), a luciferase
reporter plasmid, which upon promoter activation drives expression of firefly luciferase.
Construct Creation and Mutagenesis
To create luciferase reporters that activate specifically upon Notch dimerization,
we isolated the sequence-paired sites from the native mouse and human Hes1 and Hes5
genes and cloned these fragments into the pGL3-Basic vector (Promega) which contains a
minimal promoter that is incapable of transcriptional initiation without additional enhancer
elements. Our synthetic promoters, the 2xTP1 constructs, were designed using the TP1
response element as originally isolated from the Epstein-Barr virus, which contains two
high-affinity binding site for RBPJ 213,214. TP1’s ‘complete’ RBPJ consensus sequence (5’CGTGGGAAAAT-3’) and a ubiquitous “core” sequence (5’-GTGGGAA-3’) were taken
from the response element, its secondary site reversed and placed in the complementary
strand to result in a head-to-head arrangement, and two nucleotides were inserted into
TP1’s spacer region to result in a sixteen-base pair, sequence-paired site.
These fragments were synthesized as oligonucleotides (Integrated DNA
Technologies, IDT) and were designed to be partially complementary so that when
annealed, the ends were left overhanging, matching cuts from the restriction enzymes KpnI
and SacI (New England Biolabs, NEB). pGL3-Basic was cut with these two enzymes,
dephosphorylated with shrimp alkaline phosphatase (NEB), inserts phosphorylated with
T4 Polynucleotide Kinase (NEB), and ligated together with T4 DNA Ligase (NEB).
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A variety of sequence-paired site gap distances were created through blunt-end
ligation. PCR primers to mutate Hes1, Hes5, and 2xTP1 were designed to align with the
desired base excisions or to include base extensions. Base extensions were designed to
keep the gap distance nucleotide composition (G/C vs A/T) approximately consistent with
the native promoters’. PCR products were phosphorylated, ligated, and reaction template
digested with the restriction enzyme DpnI (NEB). A statistical comparison of the modified
constructs’ basal activity levels did not indicate the addition or subtraction of any other
regulatory elements (data not shown).
All constructs were sequenced verified before experimental use. SPS sequence
information can be found in Supplementary S3.1 table.
Western Blotting
For western blotting analyses, HEK293T cells were plated into 6-well plates at a
density of 300,000 cells/well. The following day, cells were transfected with
polyethylenimine MW 25,000 (PEI, Polysciences) at a ratio of 5 μg PEI to 1 μg DNA.
Wells were transfected with 1000 ng of plasmid DNA for the various FLAG-NICD
constructs, allowed to grow for two days, and cells collected and prepared in 1x SDS-page
lysis buffer. Western blotting was performed as described previously 157. Membranes were
incubated with primary antibodies against FLAG tag (Cell Signaling Technology, #14793)
or GAPDH (Santa Cruz Biotechnology, sc-25778) and detected through horseradish
peroxidase conjugated α-rabbit antibodies (GE Healthcare Life Sciences, NA934V).
Experiments were repeated independently three times, where the figure displayed uses the
best representative exposures.

103
Luciferase Assays
For all luciferase assays, HEK293T cells were plated into 24 well plates at a density
of 50,000 cells/well where the experimental conditions were treated as triplicates or
duplicates. The following day, cells were transfected. When analyzing the full-length
promoters, 100 ng of luciferase construct and 10 ng of NICD expression plasmid were
used, whereas in experiments of sequence-paired site constructs, 200 ng and 100 ng were
used, respectively. In all experimental variations, 10 ng of a β-Galactosidase expression
plasmid was used per well to normalize data for transfection efficiency and cell
growth/death. To equate amounts of DNA between experimental conditions, the empty
coding plasmid pcDNA3.1/MYC-His was utilized. Forty-eight hours post transfection,
cells were collected and analyzed as previously described 157. All samples were treated in
triplicates, except for the single-base change experiment, which was in duplicates.
Independent experiments were performed at least four times.
Chromatin Immunoprecipitation and PCR Analysis
Chromatin immunoprecipitation (ChIP) analyses were performed as previously
described

207

, with minor modifications. Briefly, cells were transfected with two

differentially tagged NICDs and the 2xTP1(SPS)-Core luciferase construct to act as a
dimerization target. Following formaldehyde-induced crosslinking, the nuclear fraction
was isolated and collected. Micrococcal nuclease (NEB) was used to cut the chromatin into
300-1,500 base pair fragments, the nucleus briefly sonicated to lyse the fraction, and the
DNA collected. To specifically isolate the dimerized complexes bound to DNA, they were
placed through two rounds of selection, targeting both partners within the Notch dimer.
The first round of selection was performed with anti-FLAG affinity resin (GenScript) and
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captured complexes were eluted with 3xFLAG-peptide (ApexBio). Those complexes were
further enriched through a second round of selection, probing for a HA-tagged NICD
partner, with biotinylated HA antibodies (Bioss). These targets were precipitated out of
solution with streptavidin magnetic beads (NEB) and the DNA was isolated out of the
complexes with Proteinase K (Amresco) and heat-induced reverse crosslinking. DNA was
cleaned and purified with a PCR purification kit and samples were analyzed for Notchdimer targets. To observe our synthetic luciferase construct, we used primers 5’CTAGCAAAATAGGCTGTCCC-3’, FWD and 5’-CTTTATGTTTTTGGCGTCTTCCA3’, REV. Three independent experiments were performed and the most representative
analysis was used in our figure.
Statistical Analysis
Statistical significance was determined through a student’s two-tailed t test,
comparing two-samples with homoscedastic variance. Significance is determined as *** is
p ≤ 0.001, ** is p ≤ 0.01, and * is p ≤ 0.05.
Results
Activation of Notch target genes containing sequence-paired sites requires ankyrindependent dimerization
Notch target genes often have multiple RBPJ binding sites within their promoter
sequences and a fraction of these are orientated in head-to-head, paired sites

33,35

. This

arrangement allows for NTC dimerization through NICD ankyrin domains, resulting in
potent transcription of SPS containing genes. The canonical Notch target genes Hes1 and
Hes5 have previously shown to be activated by Notch1 in a dimer-dependent manner 30,35.
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Using luciferase reporter assays, we first sought to confirm if other members of the
mammalian Notch family also activate Hes1 and Hes5 in a dimer-dependent manner.
HEK293T cells were co-transfected with commercially available luciferase
reporter plasmids containing large fragments of the Hes1 or Hes5 promoters, and either
wild-type or dimerization incompetent Notch1–4 NICD expression plasmids to observe
dimerization dependence of these promoters. In agreement with previous work, the fulllength Hes1 (Figure 3.1A) and Hes5 (Figure 3.1B) constructs were significantly activated
by wild-type N1ICD and transcriptional activation was significantly less for dimer
incompetent N1ICD. Likewise, wild-type N2ICD and N3ICD also displayed activation on
both promoters but dimer-dependent activation only on the Hes1 promoter. Indeed, mutant
N2ICD and N3ICD dimer incompetent constructs demonstrated a similar ability to activate
the Hes5 promoter suggesting the N2ICD and N3ICDs were functioning in a dimerindependent manner on the Hes5 promoter. Finally, N4ICD activated the Hes1 promoter
to a similar degree as the other NICDs but was significantly weaker on the Hes5 promoter
compared to the other NICDs. Moreover, N4ICD failed to demonstrate dimer dependence
on either the Hes1 or Hes5 promoters. In agreement with previous observations 29, western
blot analysis of the various NICDs demonstrated that the decreased transcriptional
activation of the dimer incompetent ankyrin mutant NICD molecules was not associated
with decreased protein expression of these mutant NICDs (Figure 3.1C). Moreover,
mutation of NICD ankyrin domains did not impinge the basal transcriptional activity of
NICD molecules since WT and ankyrin mutant NICDs exhibited nearly identical
transcriptional activity on the non-dimerizing 4xTP1 promoter (Figure 3.1D).
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Collectively, these results largely supported the previously reported dimerdependent nature of the Hes1 and Hes5 promoters. However, we also noted several
weaknesses with these experiments. In particular, we noticed significant background with
modest activation of the Hes1 promoter and reduced dimer dependence for N2-4ICD on
the Hes5 promoter. Based on these weaknesses, we more closely examined these promoter
sequences (Figure S3.1). We searched for high affinity binding sites that were defined by
the RBPJ consensus sequence TGTGGGAA, and low affinity sites that were defined as
having up to two nucleotide differences compared to the high-affinity sites. We found a
multitude of possible low affinity RBPJ binding sites in addition to the high-affinity SPS
sites previously described

28

. Based on this result, we hypothesized that the overall

promoter complexity and number of potential low affinity RBPJ binding sites within these
promoter sequences might have been responsible for the high background, low relative
activation, and dimer independence observed in our experiments. Moreover, beyond Notch
signaling, Hes genes are also controlled by a variety of other transcription factor families
217,218

, including self-regulation

219,220

, suggesting that these relatively large promoter

fragments might have been responding to both Notch specific and non-Notch
transcriptional activity. Collectively, these observations prompted us to perform further
experiments on the Hes1 and Hes5 promoters with the goal of refining these promoters into
more specific tools to monitor dimer-dependent NICD activation.
The isolated Hes5 sequence-paired site does not respond to dimerization
Our results in Figure 3.1 show that the Hes5 promoter demonstrated both stronger
activation than the Hes1 promoter and N1ICD dimer dependence.

We therefore

rationalized that isolation of the Hes5 SPS site should yield a promoter element that would
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specifically and robustly respond to NICD dimerization. We isolated the mouse and human
Hes5 SPS elements containing two head-to-head orientated RBPJ binding sites separated
by a 16-nucleotide gap, and the 4 to 5 surrounding nucleotides (Figure 3.2A) as previously
described

30

and cloned these sequences into a luciferase reporter vector containing a

minimal promoter that was incapable of transcriptional initiation without additional
enhance elements. Interestingly, this cloned region includes one canonical RBPJ binding
site and a partnered “cryptic site” which doesn’t match standard RBPJ binding sequences,
but instead was hypothesized to form the partner site for the high-affinity site

30

. In

addition, there are two nucleotide differences between the mouse and human genes in this
region (Fig 3.2A), one of which is inside the cryptic RBPJ binding site. As shown in Figure
3.2B, we found that both mouse and human isolated Hes5 SPS promoters were indeed
responsive to N1ICD, however, neither of these isolated elements appeared to be dependent
on NICD dimerization since they were equivalently activated by WT and dimerincompetent versions of N1ICD. In addition, the isolated Hes5 SPS responded to Notch
activation almost exactly the same as to promoters with RBPJ binding sites in a nondimerizing head-to-tail orientation (i.e. 2xTP1(H-T) and 4xTP1(H-T) constructs).
Moreover, N1ICD activated the Hes5 SPS construct less than the 2xTP1 construct despite
these promoters both containing two RBPJ binding sites. Interestingly, N4ICD was unable
to activate transcription from the isolated Hes5 SPS sites despite successfully activating
the full length Hes5 promoter in Figure 3.1. In stark contrast to this result, the full-length
Hes5 promoter did display dimer dependence to N1ICD (Figure 3.1B). This difference
between the full-length and SPS versions of the Hes5 promoter suggested that the Hes5
promoter might have been functioning differently than previously thought. Given the
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weakness of the cryptic RBPJ binding site, the presence of several other potential RBPJ
binding sites within the full-length promoter, and the dimer dependence of the full-length
Hes5 promoter, we hypothesized that the high affinity RBPJ binding site might be making
a long-distance interaction with another high-affinity site within the promoter. This
possibility would allow cooperation between previously thought independent NTCs within
gene promoters and enhancers and perhaps explain the transcriptional differences between
full-length and SPS versions of the Hes5 promoter. To test this possibility, we designed a
series of Hes5 SPS mutants based on the helical nature of DNA. Since a DNA helix
completes approximately one rotation every 10 bp, we hypothesized that an insertion or
deletion of five extra base pairs would place the secondary NTC on the opposite side of the
DNA, breaking any cooperativity. Further, an addition of an extra five nucleotides may
restore cooperativity, despite the NTC being further away, due to a long range NTC
dimerization. However, no obvious cooperative binding, or loss thereof, was observed in
these constructs (Figure 3.2C).
Collectively, these results indicated that the Hes5 SPS does not function in a dimerdependent manner in cells and instead behaves as a monomeric RBPJ binding site. Due to
this unexpected complication, to further explore SPS capabilities we moved on to the Hes1
promoter, which contains a more canonical SPS site.
The Hes1 SPS acts through traditional NICD dimerization mechanisms
Hes1 is another Notch target gene which demonstrates dimer-dependence. Its
promoter contains a single canonical RBPJ binding site and secondary site 16 nucleotides
away in the reverse orientation (Figure 3.1A). This secondary site is slightly nonconsensus, but only displays a minor decrease in RBPJ affinity compared to the high
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affinity consensus site 35,160. Therefore, we took the same reductionist approach used with
Hes5 and isolated the SPS element out of the Hes1 promoter.
Since the human and mouse sequences in this promoter region are identical, a
generic Hes1(SPS) construct was cloned into a minimal promoter luciferase vector to
quantitatively monitor its activation by Notch signaling (Figure 3.3A, Top). As before,
transfections of this construct into HEK293T cells, along with WT or ankyrin mutated
NICDs, allowed us to analyze dimer dependence of the Hes1 SPS element. The Hes1(SPS)
construct responded to NICD activation (Fig 3.3A, Bottom) and interestingly, the isolated
Hes1 SPS demonstrated approximately 5 times greater sensitivity to N1ICD compared to
the full-length Hes1 promoter, most likely due to reduced background of the isolated SPS
construct. Both N1ICD and N2ICD ankyrin mutants showed a significant decrease in
activation compared to their wild-type counterparts. In comparison, N4ICD was again
dimer independent, matching trends observed on the counterpart full-length promoter
(Figure 3.1A). Finally, N3ICD only weakly activated the isolated Hes1 SPS. Indeed,
compared to the full-length Hes1 promoter, N3ICD showed no increased activity on the
isolated Hes1 SPS. Moreover, N3ICD did not demonstrate dimer dependence on the
isolated Hes1 SPS but did demonstrate dimer dependence on the full-length Hes1 promoter
(Figure 3.1A). This is potentially unsurprising since Notch3 has been shown to
synergistically utilize other nearby transcription factors for its own signaling responses 28,
which would be lacking in this minimalized promoter.
With a properly responding SPS-driven promoter, we again wanted to determine if
long-range interactions were possible between RBPJ binding sites. We again followed the
same logic employed when mutating the Hes5 SPS and we created gap distances in steps
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of five nucleotides to take advantage of the periodicity of the DNA helix. We found that
the wild-type, 16-nucleodtide gap, was the only distance all NICDs were capable of
cooperatively binding and eliciting activation on (Figure 3.3B). This observation further
limits the options of dimerization dependent signaling since independent NTC sites within
this promoter are unlikely to cooperate over long distances by methods of kinking, looping,
or untwisting the gap DNA.
Establishment of a high activity, NICD dimer-specific reporter construct
Having found that the SPS element isolated from the Hes1 promoter functions in a
dimer-dependent manner, we next sought to optimize an SPS-driven luciferase construct
as a tool to specifically study the transcriptional activity of NICD dimers. To accomplish
this, we constructed a synthetic SPS site that contained two high-affinity RBPJ binding
sites in a head-to-head configuration separated by 16 bp. We utilized the complete TP1
consensus sequence (5’-CGTGGGAAAAT-3’) originally described by Meitinger et al., 213
thus forming the 2xTP1(SPS)-Complete construct. RBPJ shows high affinity towards this
site and multiple copies of this RBPJ binding site have previously been arranged in a headto-tail orientation to measure the activation of Notch signaling 214,221,222. These sequences
however have not previously been orientated in a head-to-head orientation to measure
transcriptional activation by dimerized NICD molecules.
As shown in Figure 3.4A, the 2xTP1(SPS)-Complete construct successfully
responded to Notch signaling. Unexpectedly however, dimer-incompetent N1ICD mutants
increased activation even better than wild-type proteins indicating this promoter was not
dimer-dependent. We hypothesized that since the last three nucleotides in the consensus
sequence were not necessary for RBPJ-DNA interactions 213, this effectively resulted in a
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22 nucleotide gap distance between RBPJ binding sites, and therefore the promoter lost its
dimerization dependence. In response to this possibility, we created another SPS construct,
this time with a core, essential sequence for RBPJ responsiveness (5’-GTGGGAA-3’) 17,213
separated by 16 bp. We named this new construct the 2xTP1(SPS)-Core construct. Cloning
of this fragment resulted in a ‘T’ on the 5’ side of each core sequence. This addition
coincidentally matches the RBPJ consensus sequence found in Hes1/5, though this position
within the consensus is variable

161

. As shown in Figure 3.4B, wild-type N1, N2, and

N3ICD all strongly activated this promoter while the corresponding dimer-incompetent
ankyrin domain mutants demonstrated significantly reduced transcriptional activity.
N4ICD also activated the promoter, but remained dimerization independent, which has
persisted across all SPS promoter variations tested. Nonetheless, the 2xTP1(SPS)-Core
construct appeared to be an optimized promoter for evaluating dimer-dependent Notch
signaling.
To ensure that NICD proteins were in fact forming dimers on the 2xTP1(SPS)-Core
construct, we performed a “proof of concept” ChIP analysis of NICD partners binding to
the Core promoter (Figure 3.4C). Our goal in this experiment was not to attempt to
quantitate binding or cooperative binding, but instead to enable for a more direct
visualization of NICD molecules in the head-to-head orientation. To enable this, it was
necessary to transfect cells with two differentially tagged NICDs (Flag- or HA- variants of
N1 and N4ICD) in unison and perform a two-step IP, first with anti-Flag antibodies and
second with anti-HA antibodies. This was required to enable both the isolation of
dimerized NICDs and the exclusion of monomeric NICDs. Moreover, this procedure was
also required for the identification of potential N1ICD/N4ICD heterodimer pairs since
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heterodimers could only be distinguished from homodimers based on the two-step co-IP
approach. In addition to the anti-FLAG + anti-HA two-step Co-IP procedure, we also cotransfected cells with the 2xTP1(SPS)-Core construct and detected this construct by PCR
of the final precipitate. This was essential for the elimination of false positives since this
luciferase construct only has two RBPJ binding sites. In contrast, native Notch target genes
such as Hes5 and Hes1 have multiple monomeric RBPJ binding sites in addition to their
SPS element (Figure 3.1) that likely could result in the recovery of false positive NICDs
bound to non-dimerizing sites. To control for non-specific isolation of DNA by Co-IP, we
also performed negative controls consisting of either 2xTP1(SPS)-Core transfected alone,
or 2xTP1(SPS)-Core transfected with HA-tagged NICD that were subjected to the twostep Co-IP. A positive control reaction was transfected with 2xTP1(SPS)-Core and Flagtagged N1ICD but only subjected to one-step IP with anti-Flag antibodies. As shown in
Figure 3.4C, PCR with primers extending over the 2xTP1(SPS)-Core promoter sequence
successfully detected DNA in the single IP positive control reaction indicating the presence
of (at least) monomeric N1ICD bound to DNA. Importantly, DNA was also detected in
the N1ICD and N4ICD homodimer samples. Moreover, PCR also detected DNA in the
N1ICD/N4ICD sample suggesting that N1ICD + N4ICD heterodimer complexes were also
present in transfected cells. Finally, DNA was not detected if no NICD molecules were
transfected or if only a single HA-tagged NICD was transfected.
Non-optimal SPS sites select against transcriptional activation by NICD dimers
The results in Figure 3.4A revealed an interesting phenomenon wherein nondimerizing ankyrin mutant NICDs performed better than their WT counterparts on the
2xTP1(SPS)-Complete construct which had a slightly longer gap than the 16 bp preferred
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by NICD molecules. This observation suggested that two RBPJ binding sites gapped
slightly more or less than 16 bp within a promoter might actually suppress promoter
responsiveness to NICD dimer-dependent Notch signaling and favor NICD dimerindependent Notch signaling, a phenomenon which has not been previously described. To
test this hypothesis, we compared WT and ankyrin mutant N1ICD transcriptional
activation from the Hes1(SPS) and 2xTP1(SPS)-Core constructs which we modified to
contain head-to-head RBPJ binding sites separated by 11, 16, or 21 bp. As shown in Figure
3.5A and 3.5B, WT N1ICD strongly activated reporter transcription on the 16 bp gap
promoters and was significantly weaker on the 11 bp and 21 bp gap promoters. Moreover,
the ankyrin mutant N1ICD also performed as expected, showing no synergistic activity
across the various gap distances. Importantly however, the ankyrin mutant N1ICD slightly
outperformed the WT N1ICD on the 11 bp and 21 bp gap promoters (Figure 3.5A and B
right panels). This observation suggested that head-to-head orientated RBPJ binding sites
with non-optimal gap widths are more likely to be activated by non-dimerizing NICD
molecules.

Whether or not there is a condition that actively manipulates NICD

dimerization is currently unknown.
A restrictive spacer range dictates the signaling capabilities of NICD dimerization
Having established a highly active and NICD dimer-specific promoter, we set out
to compare the promoter specificity of the various NICD molecules. To accomplish this,
we established a series of 2xTP1(SPS)-Core promoters with modified SPS gap distances
ranging from 11 to 21 bp in one bp increments. Combinations of each NICD protein
coupled with each spacer variation were then transfected into HEK293T cells and assayed
for their transcriptional activity. Our rational for this approach was the previous finding
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that ChIP-Seq screening identified SPS-driven genes with various gap distances, from 1121 base spacers 33. Our data in Figure 3.3 did not support the idea that gap distances greater
or less than 16 bp (in 5 bp increments) can support dimer-dependent transcription on the
Hes1 promoter. Nonetheless, we wanted to use our optimized promoter to investigate the
possibility that smaller variation in gap distances may be tolerated during NICD
dimerization, or that different Notch family members may exhibit slightly different
preferences in SPS gap width. As shown in Figure 3.6, all mouse NICDs have a strong
preference for the SPS sites with 16 bp gaps, with little room for variation. For N1ICD,
there was some flexibility observed with 15 and 17 bp spacers, though anything outside of
this range did not demonstrate cooperative signaling (Figure 3.6A). In contrast, N2ICD
showed even more specificity, where there was only slight cooperativity at the 15 bp gap,
and none observed at 17 (Figure 3.6B). N3ICD showed cooperativity at 16 bases (Figure
3.6C), and N4ICD at 16 and 17 bases (Figure 3.6D), however it’s difficult to make a
judgement call about their flexibility due to their low activation and their apparent
dimerization independent signaling. Also, it’s worth noting is that N4ICD preferred a 16
bp gap suggesting that N4ICD was functioning as a dimer which is in conflict with our
earlier observations that N4ICD functioned dimer-independently. Moreover, N4ICD
demonstrated slight inhibition on promoters with 11 or 14 bp gaps, which was similarly
observed in the Hes5 (Figure 3.2C) and Hes1 (Figure 3.3B) SPS promoter constructs. This
might indicate that N4ICD proteins generally act as transcription inhibitors on monomeric
NTC sites, or perhaps occupy RBPJ binding sites and prevent other NICDs from binding,
though we did not explore these possibilities. Further we also observed a slight increase in
activation of the 12 or 13 bp gap constructs for all four NICD proteins, which could be
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attributed to some form of cooperativity, though we did not explore this thread any further.
Finally, as with the Hes5(SPS) and Hes1(SPS), we extended the gap distances of the
2xTP1(SPS)-Core out to 36 nucleotides and again observe little to no long-range
cooperativity.
Discussion
Notch signaling is an important cellular communication mechanism that is required
for multicellular organisms. Ongoing research continues to reveal how Notch functions
and how Notch signaling is integrated into many facets of cell biology. Despite our
growing understanding of Notch function, however, there are basic questions about Notch
signaling that remains to be addressed. In this study, we sought to address some of these
basic questions about Notch signaling that have been overlooked in the quest to dig into
the deeper questions of Notch function.

In particular, we felt that a head-to-head

transcriptional comparison of the full-length Notch NICD molecules on a variety of
promoter elements should be performed. Most of what we know about Notch dimerization,
including how the proteins interact and on which promoters, comes from studies with
Notch1. While the four mammalian Notch proteins are mostly homologous within the Nterminal and ankyrin domains, there are substantial differences within the C-terminal
regions. Notably, this domain is absent in much of the field’s previous characterization
work. Indeed, molecular modeling

29

and crystallization

30

were performed with just the

ankyrin domain, and these studies laid the original groundwork for the NTC’s spatial
conformations, interacting amino acids, and DNA preferences. Similarly, further in vitro
work with EMSAs and FRET assays supported NTC cooperative loading and SPS gap
preferences, though these were performed using N1ICDs with just the N-terminal RAM
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and ankyrin domains 29,30,35. Importantly, the C-terminus has known transcriptional effects
52

, regulatory capacity

135

, and contains a multimerization site

32

. Therefore, it was

important to ensure 1) the presence of these domains don’t interrupt dimerization responses
in a cellular context, and 2) if the lessons learned by studying Notch1 can be broadly
applied to the other mammalian Notch proteins.
To address these concerns, we first revisited full-length, Notch-responsive
promoters, which contain canonical sequence-paired sites to drive transcription. While
these promoters did require NICD dimerization for full activation and therefore allowed
for preliminary conclusions, our data collection suffered from low activation levels (Hes1)
or high experimental variability (Hes5). This is a logical byproduct from using full-length
promoters since these genes are regulated through mechanisms beyond just Notch signaling
and overexpression of constitutively active NICDs would have wide, overarching,
signaling outcomes. For example, as in the case of Hes1, this gene is understood to be selfregulated, resulting in its oscillatory nature

223

. For our purposes, this implies that

endogenous Hes1 may be activated by NICD overexpression and circles back to our Hes1luciferase promoter to negatively-regulate it, resulting in its poor overall activation. For
reasons like this, we sought to create minimalized promoters to more specifically monitor
dimerization-induced signaling.
Since synthetic promoters with tandemly arranged RBPJ sites had been previously
used to monitor Notch activity (e.g. 4xCSL-Luc,

216

), we reasoned that the SPS alone

should also be sufficient for Notch activation. Therefore, we isolated the known sequencepaired sites out of Hes1 and Hes5 and created the Hes1/5(SPS)-luciferase vectors. Since
the reverse sites within Hes1 and 5 do not perfectly match the canonical RBPJ binding site,
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we also crafted the synthetic 2xTP1(SPS)-Core promoter to make a “perfect” SPS element.
Upon testing we found that the Hes1(SPS) and the 2xTP1(SPS)-Core promoters operated
as expected in that they were robustly activated by N1ICD and inefficiently activated by
dimer-incompetent NICD ankyrin mutants. Surprisingly however, our results did not
indicate that the isolated Hes5 SPS site functions in a dimer-dependent manner, although
the full-length Hes5 promoter was dimer-dependent. We return to this point later in this
discussion.
Having established two reporters with high activity and specificity for dimerized
NICD signaling we were able to specifically ask questions about dimerization of full-length
NICD proteins in cells. We found that full-length N1ICD and N2ICD activated sequencepaired sites in a dimerization-dependent mechanism. In contrast, N3ICD’s activation of
these minimal promoters was poor, which may be partially attributed to its lack of a TAD
domain in its C-terminal

52

or usage of other transcription factors for its activation 28. It

also differed in its dimer-dependence; where it was not dimer-dependent on the Hes1(SPS)
but was on the 2xTP1(SPS)-Core. This implies there is some difference located within
these two minimalized constructs that can affect dimerization outcomes. The primary
source of variation can be found within the 16 bp gap between RBPJ binding sites. The
original crystallography studies found that the Hes1 gap distance DNA must go through
substantial untwisting to bring the ankyrin domains into contact with each other for
dimerization 30. Gap composition of the 2xTP1(SPS)-Core construct has even higher G/C
content than Hes1’s, so while N1ICD and N2ICD can utilize variable gap compositions,
perhaps N3ICD utilizes a more inflexible gap sequence. Whether or not this would enable
differential transcriptional activity of Notch remains to be tested. We also found that
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N4ICD activated these promoters and our ChIP data indicated that N4ICD formed homoand heterodimers on DNA. In contrast, however, N4ICD did not appear to have dimerdependent activation on the Hes1(SPS) or 2xTP1(SPS)-Core constructs despite still
displaying a preference for a 16 bp gap between RBPJ binding sites on these promoters.
Based on these results, we believe that the single R1685A mutation (which ablates
dimerization of the other NICDs) on N4ICD was insufficient to abolish its dimerization
activity suggesting that perhaps N4ICD has an alternative dimerization interface. Indeed,
crystallography work on human N1ICD homodimers indicated two other amino acids
(K1945 and E1949) beyond the R1984 that are involved in ankyrin-mediated dimerization
30

. Interestingly the N4ICD is the only NICD with an “R” located at the K1945 site,

suggesting this position may be especially important for N4ICD dimerization (Figure
S3.2).
In addition to comparing the activation parameters of the various NICDs on these
optimized promoters, we were also curious about the standard 16-nucleotide gap distance
established by the N1ICD containing tripartite complex. Two hypotheses presented
themselves to us. First, given the contortion of DNA evident in the crystalized N1ICD
trimeric complex, we hypothesized that RBPJ sites outside of the optimal 16 bp gap might
be utilized through further contortions of DNA between RBPJ binding sites. Second, we
further hypothesized that given the variable sequences and sizes of the NICD proteins,
different NICDs might have preferences for slightly longer or shorter gap distances
between RBPJ binding sites. To test the first hypothesis, we created SPS sites with variable
gap distances in 5 bp increments to take advantage of the periodicity of helical DNA. We
found that none of these long-range alternative gap distances, for any of the NICDs, had
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significantly enhanced signaling above monomeric signaling. This indicated that longrange interactions between NTC complexes are unlikely to occur. Our analysis however
only extended to measuring 36 bp gaps and therefore, longer-range interactions between
RBPJ binding sites cannot be ruled out. To address the second hypothesis (that different
sized NICDs might have subtle differences in SPS preference), we compared NICD activity
on SPS sites with 11-21 bp gap distances in one bp increments. Similar to previous results
30,35,51

, we found that all full-length NICDs also prefer a 16 bp gap distance, with little

room for variation. Based on this result, we conclude that the C-terminal regions of NICDs
do not appear to change the SPS dimensions preferred by NICDs nor impact NICD
dimerization. It should also be stated, however, that deletion of the N1ICD C-terminal tail
(ΔS2184) which contains the trans-activation domain (TAD) significantly reduced
transcriptional activity (Figure S3.3). Minor differences in the NICDs however were
observed. For example, N2ICD appeared slightly more restrictive when choosing SPS sites
than Notch1, since N2ICD activated 15/16 bp spacers but not the 17 bp gap. This poses an
interesting possibility where N1ICD might dimer-dependently activate CUL1 or TXN2,
which have SPSs with a 17-nucleotide gap distance

30,33

, whereas binding of N2ICD on

this promoter would only cause monomeric levels of transcription, though this idea was
left untested. While N3ICD and N4ICD had questionable dimerization activities, they did
seem to have cooperative binding and higher activity on the 16/17 bp gap SPSs. Making
firm conclusions about their preferences is difficult however due to their low overall
activity and high variability. Together, these experiments highlight the stringent
requirements for dimerization-induced transcription.
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Our results have also shed some light on the nature of NICD dimerization. First,
there has been some debate as to the order of events leading up to NICD activated
transcription. It is currently unclear whether individual NICD molecules first bind to
RBPJ/DNA then form dimers, or alternatively if two NICDs first form a dimer, then bind
to RBPJ/DNA. In Figure 3.4 and 3.5, we demonstrated that dimer-incompetent N1ICD
performed slightly better than WT N1ICD on SPS elements with non-optimal 11 or 21 bp
gaps. This suggests that the attempt to dimerize may impede NICD molecules from
binding to these sites and might be a clue as to the mechanics of NICD function. Our result
indicates that non-optimal SPS elements discourage NICD dimer formation and we believe
this is evidence that NICD molecules are pre-forming dimers before binding to
RBPJ/DNA. Whether or not this has an actual impact on how promoters with non-optimal
SPS sites are utilized by Notch signaling remains to be seen but as shown by Castel et al.,
33

, several Notch responsive promoters with non-optimal SPS elements have been

identified. Another outstanding question about NICD dimerization is whether or not NICD
molecules can engage in heterodimerization. Given the conservation of sequence in the
ankyrin domains and the importance of ankyrin domains for NICD dimerization it has been
hypothesized that NICD heterodimers may exist. While further research on this topic is
certainly warranted, our results in Figure 3.6 showing similar SPS element preferences and
in Figure 3.4 showing ChIP recovery of N1/N4 complexes suggests that heterodimers
between N1ICD and N4ICD can form in transfected 293T cells and therefore possibly
under more physiological conditions. Here again, the biological implications of this
observation are unknown but given the strong differences in transcriptional activation
between N1ICD and N4ICD, we hypothesize that N1/N4ICD heterodimers would have
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intermediate

activity compared

to

N1ICD

or

N4ICD

homodimers.

Thus,

heterodimerization of NICD molecules may offer a new mechanism to regulate outputs
from Notch signaling.
Finally, our minimized Hes5(SPS) promoter was not sufficient to elicit
dimerization-dependent activation. The Hes5 promoter does not contain a canonical
sequence-paired site and instead has been described as ‘cryptic’ 30, with a standard forward
RBPJ binding site but an abnormal reverse site. When arranged as a palindrome in a SPS,
this abnormal reverse site does not support dimerization, yet it facilitated dimerization
when paired with a strong RBPJ binding site

35

. Work with EMSAs of this cryptic SPS

showed that N1ICD homodimers can form, and dimerization-dependent activation through
this site was supported through luciferase assays 30, but distinctly, these luciferase assays
were still performed with the full-length promoter. In our analyses we isolated out this SPS,
which should be sufficient for dimerization, yet this construct did not demonstrate
dimerization-dependent activation.
This inconsistency poses two thought-provoking problems. First, and as originally
described by Severson et al.

35

, if cryptic sequence-paired sites are capable of forming

NICD dimers, then searching for SPSs by ‘sequence-gazing’ becomes far more difficult.
For example, previous ChIP work isolated out RBPJ-bound DNA targets, and these
sequences were screened for nearby RBPJ binding motifs located in tandem 33. The issue
here lies in the partner sequence, wherein any non-conforming RBPJ sequences would be
missed through a simple screening approach. To further identify other cryptic sequencepaired sites, like those in Hes5 or pTα 30,31, we propose that a logical course of action is to
perform ChIP-Seq on a double-selected pool of DNA, as in our simplified ChIP
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experiment. The second problem concerns the activation of Hes5 through its SPS. While it
appears that NTC complexes dimerize on this promoter segment in vitro, do they still form
in living cells and if so, what’s the missing link for transcriptional activation? Other than
the cryptic RBPJ binding site, the Hes5(SPS) construct is nearly identical to the Hes1(SPS)
and 2xTP1(SPS)-Core constructs which respond as expected. Since the full-length Hes5
promoter is apparently dimer-responsive and the other minimalized SPS constructs are
sufficient for activation, we predict that there are other promoter elements involved which
enable these low-affinity dimers to form and signal in a cellular context. Comparing the
promoters and enhancers of multiple, cryptic, SPS genes may identify other sequence
motifs in common and identify signaling or regulatory pathways involved.
In conclusion, since much of the work on NICD dimerization has been performed
studying C-terminally truncated N1ICD, we felt it was important to 1.) examine full-length
NICD molecules to insure the C-terminal domain does not affect NICD promoter
preference, and 2.) compare promoter preferences of the other NICD molecules, which
have been largely overlooked. In so doing, we confirmed that while the C-terminal domain
of the various NICDs has a transcriptional role, this domain does not appear to play a role
in promoter preference. In addition, we also found that all the mammalian NICDs have
remarkably similar SPS gap length preferences with only minor (+/- one bp) flexibility.
Overall, these results both support previous work but also help fill in missing gaps in our
understanding of Notch transcriptional activity.
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Figure 3.1:

Dimerization dependence of full-length Hes1 and Hes5 promoters

HEK293T cells were transfected with portions of the (A) Hes1 (-467 to +46) (B) Hes5 (800 to +73) promoters for luciferase assays to monitor promoter activation. Cells were
co-transfected with wild-type (WT) or ankyrin mutated (R→A) NICDs to compare their
dimer dependence. Shown are the average +/- SE of 5 independent experiments. *
indicates P<.05, **<.01, ***<.001 (student’s t-test). (C) Western blots to compare the
protein abundancies of WT or dimer incompetent ankyrin mutated NICDs. HEK293T
cells were transfected with NICD expression constructs and NICD proteins were detected
with anti-Flag antibodies. Endogenous GAPDH was also detected from the same lysates
for use as a loading control. The image displayed is a representative blot from an
experiment that was replicated three independent times. (D) 293T cells were transfected
with the dimer independent 4XTP1 luciferase construct and WT or ankyrin mutated
NICDs as above. Shown are the average +/- SE of three independent experiments.
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Figure 3.2:

Lack of dimerization dependence of the Hes5 sequence-paired site

(A) Promoter structure of the Hes5, 2xTP1(H-T), and 4xTP1(H-T) luciferase constructs.
Red dots indicate nucleotide differences between the human and mouse Hes5 SPS sites.
Suspected RBPJ binding sites are highlighted in yellow and arrows depict directionality
of RBPJ binding sites. (B) HEK293T cells were transfected with either the mouse
(mHes5(SPS)) or human (hHes5(SPS)) sequence-paired site constructs or with the
2xTP1(H-T) or 4xTP1(H-T) head-to-tail constructs and WT or dimer-null versions of
NICDs. Shown is the average +/- SE of n = 4 independent experiments. * <0.05, **
<0.01, *** <0.001, student’s t-test. (C) HEK293T cells were transfected with various
NICDs and Hes5 SPS constructs with 11 – 36 bp spacer regions (5 bp increments), n = 6.
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Figure 3.3:

Dimer dependence of the Hes1 sequence-paired site

(A, Top) Sequence information for the human and mouse isolated Hes1 SPS element. (A,
Bottom) HEK293T cells were transfected with the Hes1(SPS) construct and WT or
dimer-null versions of NICD proteins. Shown is the average +/- SE of n = 4 independent
experiments. Student’s t-test was performed to compare the activation between WT and
mutant NICDs where * <0.05, ** <0.01, *** <0.001. (B) HEK293T cells were
transfected with various NICDs and Hes1(SPS) constructs that had been modified to
contain variable gap distances between RBPJ binding sites in 5 bp interments. Shown is
the average +/- SE of 4 independent experiments.
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Figure 3.4:

An optimized Notch responsive SPS element

(A and B) A synthetic SPS-driven promoter, using the (A) complete TP1 binding element
or (B) core TP1 binding element, was transfected into HEK293T cells. These two
constructs were activated with either wild-type (WT) or ankyrin mutated (R→A) NICDs
to observe their dimer responsiveness. Shown are the average +/- SE of n = 4
independent experiments. Student’s t-test was performed to compare the activation
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between WT and mutant NICDs where * <0.05, ** <0.01, *** <0.001. (C) ChIP was
used to confirm NICD dimer formation on the 2xTP1(SPS)-Core construct. HEK293T
cells were transfected with various combinations of plasmids encoding FLAG-tagged
NICD and HA-tagged NICD proteins. NICD dimers were detected by
immunoprecipitation first with anti-FLAG antibodies then with anti-HA antibodies
followed by PCR to detect the co-transfected 2xTP1(SPS)-Core construct. Positive
control reaction was subject to a single round of selection with anti-FLAG antibodies.
Negative controls were transfected with 2xTP1(SPS)-Core alone or 2xTP1(SPS)-Core
and HA-N1ICD then subjected to both anti-FLAG and anti-HA immunoprecipitation.
Shown is a representative image of a single experiment that was performed three
independent times.
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Figure 3.5:

Non-optimal SPS sites select against dimer-dependent NICD
transcriptional activation

(A and B) 293T cells were transfected with 11, 16, or 21 bp gap versions of the (A)
Hes1(SPS) or (B) 2xTP1(SPS)-Core reporters and WT or ankyrin mutated N1ICD.
Shown is the average +/- SE of n = 6 experiments. In all panels, a student’s t-test was
performed to compare the activation between WT and ankyrin mutated NICDs, where Pvalues are reported as * <0.05, ** <0.01, *** <0.001.
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Figure 3.6:

Notch homodimers do not tolerate alternative gap distances

(A-D) HEK293T cells were co-transfected with various NICD expression plasmids and
2xTP1(SPS)-Core promoter with varying SPS gap lengths from 11-21 bp, in one bp
increments, or 21-36 bp, in 5 bp increments. For all luciferase studies, an empty
expression vector was used to equate the amount of DNA transfected across samples.
Fold differences are represented as the NICD-induced activity compared to the basal
activity levels. Shown are the average +/- SE of n = 5 independent experiments. (E)
Overlay of data in panels A-D to emphasize different transcriptional strengths of the
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various NICDs. Statistical analysis was performed by using a one-way analysis of
variance (ANOVA), followed by a Tukey-Kramer's HSD post-hoc test. Only points that
were statistically different from other points are indicated in each graph where capital
letters indicate P values < 0.001, whereas small case letters indicate P < 0.05 on a pointby-point basis.
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Figure S3.1: Identification of low and high affinity SPS sites in Hes1 and Hes5
promoters

DNA sequences are as reported for AddGene products Hes1-luciferase (#41723) and
Hes5-luciferase (#41724) vectors. Possible high and low affinity sites (as described in
material and methods) are indicated by forward or reverse arrows. High affinity sites
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confirmed to serve as RBPJ binding sites are indicated with red shading. Nucleotides
that diverge from the core TP1 element as originally defined (C/tGTGGGAA) are
indicated by bolded letters.
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Figure S3.2: Sequence comparison of human N1ICD and mouse NICD
dimerization domains

Amino acids previously identified as important for dimerization of N1ICD ankyrin
domains are indicated 30. Amino acid numbers are based on equivalent positions in
human N1ICD. R1984A equivalents were used throughout this work to attempt to make
generate dimer-incompetent NICD variants.
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Figure S3.3: N1ICD C-terminus does not impact NICD dimerization

HEK293T cells were transfected with 11, 16, or 21 bp versions of Hes1(SPS) or
2xTP1(SPS)-Core luciferase reporters and either full-length N1ICD or ΔS2184 N1ICD
(which deletes residues C-terminal of the N1ICD ankyrin domain). Shown is the average
+/- SE of four independent experiments.

317
318

Mouse SPS Region
(16 BP Gap)
11 BP Gap
21 BP Gap

315

CCGAGTGTGGGAACGG-----GCGCCCGGACCCCAGGCGCC
CCGAGTGTGGGAACGGCCGCG[GGCCC]GCGCCCGGACCCCAGGCGCC

CCGAGTGTGGGAACGGCCGCGGCGCCCGGACCCCAGGCGCC

CGGAGTGTGGGAACGGCCGCGGCGCCCGGACTCCAGGCGCC

Construct contains the sequence -800 to +73 around the transcriptional start site.

Full Length
(mouse sequence)

Human SPS Region

Sequence (5’→3’)

GTTACTGTGGGAAAGAAAGTT-----AGTTTCACACGAGCC
GTTACTGTGGGAAAGAAAGTT[GGAAT]TGGGAAGTTTCACACGAGCC
GTTACTGTGGGAAAGAAAGTT[GGAAT][GGAAT]TGGGAAGTTTCACACGAGCC
GTTACTGTGGGAAAGAAAGTT[GGAAT][GGAAT][GGAAT]TGGGAAGTTTCACACGAGCC
GTTACTGTGGGAAAGAAAGTT[GGAAT][GGAAT][GGAAT][GGAAT]TGGGAAGTTTCACACGAG
CC

Description

11 BP Gap
21 BP Gap
26 BP Gap
31 BP Gap
36 BP Gap

Construct contains the sequence -467 to +46 around the transcriptional start site.

Full Length
(mouse sequence)
Human/Mouse SPS
Region (16 BP Gap)
GTTACTGTGGGAAAGAAAGTTTGGGAAGTTTCACACGAGCC

Sequence (5’→3’)

Description

Plasmid and Sequence Information for the NICD-Activated Sequence-Paired Sites

314

Hes5
Plasmid
Number
196
AddGene #41724

338
340
341
342
343

Hes1
Plasmid
Number
344
AddGene #41723
339

Supplementary Table 3.1
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26 BP Gap

31 BP Gap

36 BP Gap

319

320

321

2xTP1 (Head-to-Head)
Plasmid
Description
Number
323
Complete TP1 Site
329
Core TP1 Site (16 BP
Gap)
324
11 BP Gap
325
12 BP Gap
326
13 BP Gap
327
14 BP Gap
328
15 BP Gap
330
17 BP Gap
331
18 BP Gap
332
19 BP Gap
333
20 BP Gap
334
21 BP Gap
335
26 BP Gap
336
31 BP Gap
337
36 BP Gap

Description

Plasmid
Number

CGACTGTGGGAAGGGCGGAA-----CGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA----ACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA---CACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA--GCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA-GGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[G]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GA]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAG]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAGG]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAGGC]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAGGC][GAGGC]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAGGC][GAGGC][GAGGC]GGGCACGGTTCCCACAGTA
CGACTGTGGGAAGGGCGGAA[GAGGC][GAGGC][GAGGC][GAGGC]GGGCACGGTTCCCACAGT
A

CGACTCGTGGGAAAATGGGCGGAAGGGCACGGATTTTCCCACGAGTA
CGACTGTGGGAAGGGCGGAAGGGCACGGTTCCCACAGTA

Sequence (5’→3’)

CCGAGTGTGGGAACGGCCGCG[GGCCC][GGCCC][GGCCC][GGCCC]GCGCCCGGACCCCAGGC
GCC

CCGAGTGTGGGAACGGCCGCG[GGCCC][GGCCC][GGCCC]GCGCCCGGACCCCAGGCGCC

CCGAGTGTGGGAACGGCCGCG[GGCCC][GGCCC]GCGCCCGGACCCCAGGCGCC

Sequence (5’→3’)
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Two TP1 Binding
Elements, Head-toTail Arrangement
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Four TP1 Binding
Elements, Head-toTail Arrangement

4xTP1 (Head-to-Tail)
Plasmid
Description
Number

261

2xTP1 (Head-to-Tail)
Plasmid
Description
Number

TTCGCCGTGGGAAAATCGCCGTGGGAAAATCGCCGTGGGAAAATCGCCGTGGGAAAATTCGA

Sequence (5’→3’)

CGACTCGTGGGAAAATGGGCGGAAGGGCACCGTGGGAAAATAGTA

Sequence (5’→3’)
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